CBME UG CURRICULUM
GENERAL MEDICINE MBBS LESSON PLAN
LECTURE NO
COMPETENCY NO
TITLES:Topic,Competency,Lesson
TEACHING METHODOLOGY
INTEGRATED TEACHING
TOPIC
HEART FAILURE
Describe and discuss the epidemiology, pathogenesis clinical
evolution and course of common causes of heart disease including:
IM 1.1
rheuma c/ valvular, ischemic, hypertrophic , inflammatory
IM 1.1 /SLO
1.Epidemiology and causes of rheumatic fever
2.Etiopathogeneisis of valvular heart disease
3. Causes for ishemic heart disease and epidemiology
4. various types of cardiomyopathies , etiopathogenesis and epidimiology
5. various types of inflammatory cardiac diseases and etipathogenesis
IM1.2
Describe and discuss the gene c basis of some forms of heart failure
IM 1.2/SLO
1.Genetic basis of heart failure
1
RHEUMATIC VALVULAR HEART DISEASE - EPIDEMIOLOGY AND ETIOPATHOGENESIS
LECTURE
PATHOLOGY
2
ISCHEMIC HEART DISEASE -EPIDEMIOLOGY,CAUSES AND PATHOGENESIS
LECTURE
PATHOLOGY
3
CARDIOMYOPATHIES- EPIDEMIOLOGY ,TYPES AND ETIOPATHOGENESIS
LECTURE
PATHOLOGY
Describe and discuss the ae ology microbiology pathogenies and
clinical evolution of rheumatic fever, criteria, degree of rheumatic
activity and rheumatic valvular heart disease and its complications
IM 1.3
including infective endocarditis
IM 1.3/SLO
1.Etiopatogenesis , microbiology of rheumatic fever
2.criteria for rheumatic fever
3.sequelae of rheumatic fever
4.causes for mitral stenosis , etipathogenesis ,clinical evaluation and management
5.causes for mitral regurgitation , etipathogenesis ,clinical evaluation and management
6.causes for aortic stenosis , etipathogenesis ,clinical evaluation and management
7.causes for aortic regurgitation , etipathogenesis ,clinical evaluation and management
4
MITRAL STENOSIS
LECTURE
5
MITRAL REGURGITATION
LECTURE
6
AORTIC STENOSIS
LECTURE
7
AORTIC REGURGITATION
LECTURE
Describe and discuss the clinical presenta on and features,
IM 1.9
diagnosis, recogni on and management of acute rheuma c fever
IM 1.9 /SLO
1.Clinical presentation of rheumatic fever
2.diagnostic criteria for rheumatic fever
3. investigations for rheumatic fever - ASO titre , throat swab , culture and sensitivity , ecg
, echo evaluation
4. treatment for rheumatic fever
Describe and discuss the role of penicillin prophylaxis in the
preven on of rheuma c heart disease
IM 1.27
IM 1.27 / SLO
1.penicillin classification
2. therapeutic uses of penicillin in rheumatic fever
3. penicillin prophylaxis - dose , duration.
4. drug prophylaxis in penicillin hypersensitivity patients
MICRO AND
8
RHEUMATIC FEVER AND PENICILLIN PROPHYLAXIS
LECTURE
PAHRMACOLOGY
Stage heart failure
IM 1.4
IM 1.4 / SLO
1. definition of heart failure
2.Staging in heart failure
Describe ,discuss and differen ate the processes involved in R Vs L
heart failure, systolic vs diastolic failure
IM 1.5
IM 1.5 /SLO
1. definition of right heart failure
2. definition of left heart failure
3. definition of systolic heart failure
4. definition of diastolic heart failure
5.Difference between right and left heart failure
6.systolic vs diastolic heart failure
Describe and discuss the compensatory mechanisms involved in
heart failure including cardiac remodelling and neurohormonal
adapta ons
IM 1.6
IM 1.6 /SLO
1.Mechanisms in heart failure
2.Neurohormonal mechanism and cardiac remodelling
9
HEART FAILURE - CLASSIFICATION AND STAGING
LECTURE
PATHOLOGY AND
10
MECHANISMS OF HEART FAILURE
LECTURE
PHYSIOLOGY
Enumerate, describe and discuss the factors that exacerbate heart
failure including ischemia, arrythmias, anemia, thyrotoxicosis, discussion discussion
dietary factors drugs etc.
IM 1.7
IM 1.7 /SLO
1. Role of ishemia in heart failure
2. Exacerbating factors of heart failure
3. Dietary factors in heart failure
4. Drugs exacerbating heart failure
5. Hyperdynamic circulatory state exacerbating heart failure
Describe and discuss the pathogenesis and development of
common arrythmias involved in heart failure particularly atrial
fibrilla on
IM 1.8
IM 1.8 /SLO
1.Tachyarrythmias and its types in heart failure
2.Bradyarrthymias and its types in heart failure
2.Definition of atrial fibrillation
3.Types of atrial fibrillation
4.Etiology of atrial fibrillation
5.Pathogeneis of atrial fibrillation
6.Diagnosis of atrial fibrillation
7.Management of atrial fibrillation
11
FACTORS EXACERBATING HEART FAILURE AND BRADYARRYTHMIAS IN HEART FAILURE
LECTURE
12
TACHYARRTHYMIAS IN HEART FAILURE
LECTURE
13
ATRIAL FIBRILLATION
LECTURE
Enumerate the indica ons for and describe the findings of heart
failure with the following conditions including: 2D echocardiography, brain natriuretic
peptide, exercise testing, nuclear medicine testing
IM 1.19
and coronary angiogram
IM 1.19/SLO
1.Brain natriuretic peptide and its role in heart failure
2. 2D ECHO - indications and interpretation
3.Stress resting and its significance
4.Nuclear medcine testing in heart failure
5. Coronary angiogram - Indications
6.Coronary angiogram procedure
14
INVESTIGATIONS IN HEART FAILURE - ECHO,STRESS TESTING AND NUCLEAR MEDICINE
LECTURE
RADIOLOGY
15
CORONARY ANGIOGRAM
LECTURE
RADIOLOGY
Elicit document and present an appropriate history
the diagnosis, cause and severity of heart failure including:
presenting complaints, precipitating and exacerbating factors, risk
factors exercise tolerance, changes in sleep patterns, features
IM 1.10
suggestive of infective endocarditis
IM 1.10
1.History for the diagnosis of heart failure
2.Causes for severity of heart failure
3.History of precipitating and exacerbating factors
4.Risk factors of heart failure
5.History regarding sleeping pattern in heart failure
6.History suggestive of infective endocarditis in heart failure
16
HISTORY DOCUMENTATION IN HEART FAILURE
SMALL GROUP DISCUSSION
Perform and demonstrate a systema c examina on based on the
history that will help establish the diagnosis and estimate its severity
including: measurement of pulse, blood pressure and respiratory
rate, jugular venous forms and pulses, peripheral pulses,
conjunctiva and fundus, lung, cardiac examination including
palpation and auscultation with identification of heart sounds and
IM 1.11
murmurs, abdominal distension and splenic palpa on
OBJECTIVES
1.Demonstrate Vital signs in heart failure
2.Measurement of bloodpressure in heart failure and interpretation
3.JVP measurement and wave patterns in heart failure
4.Peripheral pulsations and their quality
5.Examination of apical impulse in heart failure
6.Cardiac murmurs and gallop in heart failure
7.Demonstration of lung signs in heart failure
8.Demonstration of abdominal distension and hepatosplenomegaly
17
PHYSICAL EXAMINATION IN HEART FAILURE
SMALL GROUP DISCUSSION
Demonstrate peripheral pulse, volume, character, quality and
IM 1.12
varia on in various causes of heart failure
OBJECTIVES
1. Peripheral pulse in heart failure
2.Volume and character of pulse forms in heart failure
3.Quality of various pulse forms in heart failure
Measure the blood pressure accurately, recognise and discuss
alterations in blood pressure in valvular heart disease and other
IM 1.13
causes of heart failure and cardiac tamponade
OBJECTIVES
1.Recording blood pressure
2.Interpretation of Blood pressure alteration in heart failure
3.Blood pressure in valvular heart diseases
4.Blood pressure in cardiac tamponade
18
PULSE AND BLOOD PRESSURE IN CARDIAC FAILURE AND CARDIAC TAMPONADE
SMALL GROUP DISCUSSION
IM 1.14
Demonstrate and measure jugular venous distension
OBJECTIVES
1.Definition of JVP
2.Wave pattern in JVP
3.Clinical significance of JVP
4.Measurement of JVP and its interpretation
Iden fy and describe the ming, pitch quality conduc on and significance of precordial
IM 1.15
murmurs and their varia ons
OBJECTIVES
1.Definition of murmur
2.Various types of murmurs
3.Identification of systolic and diastolic murmurs
4.Interpretation of murmurs
5.Variations in intensity of the murmurs
19
JVP AND MURMURS IN HEART FAILURE
LECTURE
Generate a differen al diagnosis based on the clinical presenta on
IM 1.16
and priori se it based on the most likely diagnosis
OBJECTIVES
1.Differential diagnosis of heart failure
2. Clinical presentation for the differential diagnosis
Order and interpret diagnostic testing based on the clinical
IM 1.17
diagnosis including 12 lead ECG, Chest radiograph, blood cultures
OBJECTIVES
1.Definition of ECG
3.ECG interpretation in heart failure
4.Chest radiography interpretation in heart failure
5.Blood investigations including culture in heart failure
20
DIFFERENTIAL DIAGNOSIS AND INVESTIGATIONS IN HEART FAILURE
SMALL GROUP DISCUSSION
IM 1.18
Perform and interpret ECG
OBJECTIVES
1.Definition of ECG
2.Wave pattern in ECG
3.Recording ECG
4.Damping , underdamping and isoelectric line in ECG
5.Interpretation of ECG - Axis ,Heart rate calculation and Rhythm abnormalities
6.Interpretation of ECG - Chamber hypertrophy and conduction abnormalities
7.Interpretation of ECG -ischemia and infarction
21
ECG
SGD
Describe and discuss and iden fy the clinical features of acute and
subacute endocarditis, echocardiographic findings, blood culture
and sensitivity and therapy
IM 1.21
OBJECTIVES
1.Definition of acute and subacute endocarditis
2.Etiology
3.Clinical features of infective endocarditis
4.ECHO findings
5.Blood culture and sensitivity
6.Therapy
Assist and demonstrate the proper technique in collec ng specimen
IM 1.22
for blood culture
OBJECTIVES
1.Technique of collection of blood sample for endocarditis
22
INFECTIVE ENDOCARDITIS
LECTURE
MICROBIOLOGY
Describe, prescribe and communicate non pharmacologic
management of heart failure including sodium restriction, physical
activity and limitations
IM 1.23
OBJECTIVES
1.Dietary advice - salt restricted diet and rich potassium diet
2.Lifestyle modification
Describe and discuss the pharmacology of drugs including
indications, contraindications in the management of heart failure
including diuretics, ACE inhibitors, Beta blockers, aldosterone
IM 1.24
antagonists and cardiac glycosides
OBJECTIVES
1.Drug therapy - Diuretics,ACE inhibitors,Beta blockers,Aldosterone anatgonists and
cardiac glycosides
2.Drug doses and half life of the drugs
3.Drug side effects
4.Indications and contraindications of drug therapy
Develop document and present a management plan for pa ents with
IM 1.26
heart failure based on type of failure, underlying ae ology
OBJECTIVES
1.Management plan of heart failure
2.Management based on etiology
23
PHARMACOLOGICAL AND NON -PHARMACOLOGICAL THERAPY IN HEART FAILURE
LECTURE
PHARMACOLOGY
Enumerate the indica ons for valvuloplasty, valvotomy, coronary
IM 1.25
revasculariza on and cardiac transplanta on
OBJECTIVES
1.Valvuloplasty - Procedure and its indications
2.Valvotomy - Procedure and its indications
3.Coronary revascularisation - Procedure and its indications
4.Cardiac transplantation - Procedure and its indications
24
INTERVENTIONAL MANAGEMENT OF HEART FAILURE
LECTURE
Enumerate the causes of adult presenta ons of congenital heart
disease and describe the distinguishing features between cyanotic
IM 1.28
and acyano c heart disease
OBJECTIVES
1.Adult presentation of congenital heart disease
2.Difference between cyanotic and acyanotic heart disease
Elicit document and present an appropriate history, demonstrate
correctly general examination, relevant clinical findings and
formulate document and present a management plan for an adult
IM 1.29
pa ent presen ng with a common form of congenital heart disease
OBJECTIVES
1.History and examination
2.clinical features
3.Management
25
CONGENITAL CYANOTIC HEART DISEASES
LECTURE
26
CONGENITAL ACYANOTIC HEART DISEASES
LECTURE
Administer an intramuscular injec on with an appropriate
IM 1.30
explanation to the patient
OBJECTIVES
1. Technique for intramuscular injection
2.Sterile precautions before intramuscular injection
3.Test dosing method
3.Complications of intramuscular injection
4.Early identification of anaphylaxis and its management
27
INTRAMUSCULAR INJECTION
DOAP SESSION
PHARMACOLOGY
TOPIC
ACUTE MYOCARDIAL INFARCTION/IHD
Discuss and describe the epidemiology, antecedents and risK
IM 2.1`
factors for atherosclerosis and ischemic heart disease
OBJECTIVES
1.Epidemiology
2.Risk factors
Discuss the ae ology of risk factors both modifiable and non modifiable risk
factors.Discuss the aetiology of risk factors both modifiable and non modifiable of
IM 2.2
atherosclerosis and IHD
OBJECTIVES
1.Etiology
2.Modifiable and non modifiable risk factors
PATHOLOGY ,
PHYSIOLOGY AND
28
ATHEROSCLEROSIS AND IHD- ETIOLOGY AND RISK FACTORS
LECTURE
COMMUNITY MEDICINE
Discuss and describe the lipid cycle and the role of dyslipidemia in
IM 2.3
the pathogenesis of atherosclerosis
OBJECTIVES
1.Lipid cycle
2.Role of dyslipidemia in atherosclerosis
Discuss and describe the pathogenesis natural history, evolu on
IM 2.4
and complica ons of atherosclerosis and IHD
OBJECTIVES
1.Patholgy and clinical evolution
2.Complications
Choose and interpret a lipid profile and iden fy the desirable lipid
IM 2.12
profile in the clinical context
OBJECTIVES
1.Interpretation of Lipid profile
Discuss and describe the indica ons, formula ons, doses, side
effects and monitoring for drugs used in the management of
IM 2.18
dyslipidemia
OBJECTIVES
1.Drug dosing,indications
2.Side effects
3.Monitoring of drugs in dyslipidemia
29
LIPID CYCLE AND DYSLIPIDEMIA - CLINICAL PRESENTATION AND MANAGEMENT
LECTURE
BIOCHEMISTRY
Define the various acute coronary syndromes and describe their
IM 2.5
evolu on, natural history and outcomes
OBJECTIVES
1.Acute coronary syndrome- types
2.Natural history
3.Outcomes
Elicit document and present an appropriate history that includes onset evolution,
presentation risk factors, family history, comorbid conditions, complications, medication,
IM 2.6
history of atherosclerosis, IHD and coronary syndromes
OBJECTIVES
1.History of atherosclerosis
2.Risk factors of CAHD
3. Comorbid conditions and complications
Perform, demonstrate and document a physical examination including a vascular and
IM 2.7
cardiac examination that is appropriate for the clinical presentation
OBJECTIVES
1.Examination of CVS
2. Clinical findings Interpretation
Generate document and present a differential diagnosis based on the clinical presentation
IM 2.8
and prioritise based on “cannot miss”, most likely diagnosis and severity
OBJECTIVES
1. Differential diagnosis
2.Final diagnosis and severity
30
ACUTE CORONARY SYNDROMES - INTRODUCTION AND HISTORY TAKING
LECTURE
31
ACUTE COROINARY SYNDROMES - EXAMINATION AND DIFFERENTIAL DIAGNOSIS
LECTURE
Distinguish and differentiate between stable and unstable angina and AMI based on the
IM 2.9
clinical presenta on
OBJECTIVES
2.Angina - definition
3. unstable angina
Clinical differentiation between angina and Unstable angina
32
ANGINA - CLINICAL PRESENTATION
SMALL GROUP DISCUSSION
IM 2.10
Order, perform and interpret an ECG
OBJECTIVES
1. RECORDING ECG
2. Interpretation of ECG in Myocardial infarction
IM 2.11
Order and interpret a Chest X-ray and markers of acute myocardial infarc on
OBJECTIVES
1.Interpretation of chest Xray
2.Interpretation of markers in MI
33
INVESTIGATIONS - MYOCARDIAL INFRACTION
LECTURE
Discuss and enumerate the indications for and findings on echocardiogram, stress testing
and coronary angiogram
IM 2.13
OBJECTIVES
1.Indications for Echocardiogram
2. interpretation of echocardiogram
3. indication for stress testing
4. contraindication for stress testing
5.Indications for coronary angiogram
6.contraindication for coronary angiogram
7.preparation of patient for coronary angiogram
8.interpretation of coronary angiogram report
34
ECHOCARDIOGRAM STRESS TESTING IN CAD
SGD
35
CORONARY ANGIOGRAM IN CAD
SGD
Discuss and describe the indications for admission to a coronary care unit and supportive
IM 2.14
therapy for a pa ent with acute coronary syndrome
OBJECTIVES
1.Admission criteria for ACS
2.Supportive therapy in ACS
36
ACS - ADMISSION CRITERIA ,INVESTIGATIONS AND SUPPORTIVE THERAPY
SGD
Discuss and describe the medications used in patients with an acute coronary syndrome
IM 2.15
based on the clinical presentation
OBJECTIVES
1.drugs used in intensive coronary care unit
2.life saving drugs in the coronary care unit
3.Pharmacological therapy in ACS
37
MANAGEMENT OF ACS IN INTENSIVE CORONARY CARE UNIT
LECTURE
PHARMACOLOGY
IM 2.16
Discuss and describe the indications for acute thrombolysis, PTCA and CABG
OBJECTIVES
1.Thrombolytic therapy - Indications and contraindications
2. drugs used for thrombolytic therapy
3. dose and side effect of drugs in thrombolytic therapy
4. Indications for PTCA
5. indication for CABG
38
MANAGEMENT OF ACS - THROMBOLYTIC THERAPY , PTCA , CABG
SGD
IM 2.17
Discuss and describe the indica ons and methods of cardiac rehabilita on
Counsel and communicate to patients with empathy lifestyle changes in atherosclerosis /
IM2.24
post coronary syndromes
OBJECTIVES
1.Indications of cardiac rehabilitation
2.Methods of cardiac rehabilitation
3.Dietary advice
4. LIFE STYLE MODIFICATION in ACS
39
CARDIAC REHABILITATION IN ACS
SGD
IM 2.20
Discuss and describe the assessment and relief of pain in acute coronary syndromes
OBJECTIVES
1.Pain management in ACS
2.Drugs used for relief of pain in ACS
3. indication and contraindication of the drug
1. Pharmacalogical therapy - indications and contraindications
Describe and discuss the indica>ons for nitrates, an> platelet agents, gpIIb IIIa inhibitors,
IM2.23
beta blockers, ACE inhibitors etc in the management of coronary syndromes
1.indications for nitrates
2.drugs used in acute coronary syndrome - beta blockers, ACE inhibitors
3. uses of antiplatelet drugs and their side effects
40
PHARMACOLOGICAL MANAGEMENT OF ACS
SGD
PHARMACOLOGY
Discuss and describe the pathogenesis, recognition and management of complications of
acute coronary syndromes including arrhythmias, shock, LV dysfunction, papillary muscle
rupture and pericarditis
IM 2.19
OBJECTIVES
1. acute complication of ACS
2.chronic complication of acs
3.Pathogenesis of complications in ACS
4. clinical findings of complications and management of complications
41
ACS - COMPLICATIONS AND MANAGEMENT
LECTURE
Observe and participate in a controlled environment an ACLS program
IM 2.21
OBJECTIVES
1.Current ACLS guidelines 2020
2.Drugs used in ACLS protocol
3. Cardiac arrest Revival
42
ACS- ACLS PROGRAMME
DOAP
Perform and demonstrate in a mannequin BLS
IM 2.22
OBJECTIVES
1.Clinical significance of BLS
2.Steps in BLS
3.Demonstration of BLS
43
ACS- MANNEQUIN BLS PROGRAMME
DOAP
TOPIC
PNEUMONIA
Define, discuss, describe and dis nguish community acquired pneumonia, nosocomial
IM 3.1
pneumonia and aspira on pneumonia
OBJECTIVES
1.Difference and clinical presentation of community acquired pneumonia,
nosocomial pneumonia,aspiration pneumonia
Discuss and describe the ae ologies of various kinds of pneumonia and their microbiology
IM 3.2
depending on the setting and immune status of the host
OBJECTIVES
1) Etiology of pneumonia
2)organisms that causes pneumonia
3)Immune status of the host
Discuss and describe the pathogenesis, presentation, natural history and complications of
IM 3.3
pneumonia
OBJECTIVES
1.History of pneumonia
2.Clinical features
3.Pathogenesis
4.Complications OF Pneumonia
44
PNEUMONIA - CLASSIFICATION ,ETIOLOGY AND PATHOGENESIS
LECTURE
PATHOLOGY
45
CLINICAL PRESENTATION OF VARIOUS TYPES OF PNEUMONIA
LECTURE
PATHOLOGY
Elicit document and present an appropriate history including the evolution, risk factors
IM 3.4
including immune status and occupational risk
OBJECTIVES
1.Evolution of pneumonia
2.Risk factors - immune and occupational
Perform, document and demonstrate a physical examina on including general
examination and appropriate examination of the lungs that establishes the diagnosis,
complications and severity of disease
IM 3.5
OBJECTIVES
1.Physical examination and demonstartion of respiratory system
2.Establishing the diagnosis
3.Complication
4.Severity of pneumonia
Generate document and present a differen al diagnosis based on the clinical features, and
prioritise the diagnosis based on the presentation
IM 3.6
OBJECTIVES
1.Differential diagnosis
2.Prioritise the diagnosis based on the presentation
PNEUMONIA - HISTORY , EXAMINATION OF RESPIRATORY SYSTEM, DIAGNOSIS AND
46
DIFFERENRIAL DIAGNOSIS
SGD
Order and interpret diagnostic tests based on the clinical presentation including: CBC,
Chest X ray PA view, Mantoux, sputum gram stain, sputum culture and sensitivity, pleural
IM 3.7
fluid examination and culture, HIV testing and ABG
OBJECTIVES
1.Blood investigations- CBC, blood culture interpretation
2.Chest X-Ray PA view
3.Sputum-gram stain , culture and senstivity
4.Pleural fluid- biochemical analysis,culture and senstivity/HIV/ABG
47
INVESTIGATIONS OF PNEUMONIA
SGD
MICROBIOLOGY
IM 3.8
Demonstrate in a mannequin and interpret results of an arterial blood gas examination
OBJECTIVES
1.ABG,mannequin demonstration
2.interpretation of ABG results
48
BLOOD GAS ANALYSIS
SGD
BIOCHEMISTRY
IM 3.9
Demonstrate in a mannequin and interpret results of a pleural fluid aspiration
OBJECTIVES
1.indications for pleural aspiration
2.contraindication for pleural aspiration
3.Mannequin demonstration of pleural fluid aspiration
4.Interpretation of pleural fluid analysis report
49
PLEURAL FLUID ASPIRATION TECHNIQUE AND ANALYSIS
SGD
PATHOLOGY
IM 3.10
Demonstrate the correct technique in a mannequin and interpret results of a blood culture
OBJECTIVES
1. indications for blood culture
2.sample collection methodology
3. contraindication for blood culture
4.Mannequin demonstration of of blood culture technique
5.Interpretation of blood culture report
50
PNEUMONIA AND BLOOD CULTURE
SGD
MICROBIOLOGY
Describe and enumerate the indications for further testing including HRCT, Viral cultures,
IM 3.11
PCR and specialised testing
OBJECTIVES
1. INDICATION FOR HRCT
2.indication for viral culture
3. viral transport media and viral culture media
4. indications of PCR
5. interpretation of PCR
6.Indications for other specialised testing
MICROBIOLOGY/RADIOL
51
PNEUMONIA - SPECIAL INVESTIGATIONS
SGD
OGY
Select, describe and prescribe based on the most likely aetiology, an appropriate empirical
IM 3.12
antimicrobial based on the pharmacology and antimicrobial spectrum
OBJECTIVES
1.Antimicrobial therapy based on clinical spectrum and investigations
Select, describe and prescribe based on culture and sensitivity appropriate empaling
IM 3.13
antimicrobial based on the pharmacology and antimicrobial spectrum.
OBJECTIVES
1.Drug therapy based on culture and senstivity pattern
2.Appropriate antimicrobial spectrum
IM 3.14
Perform and interpret a sputum gram stain and AFB
OBJECTIVES
1. method of gram staining
2.AFB -zeil neilson technique
3.Interpretation of sputum-gram stain and AFB
IM 3.15
Describe and enumerate the indications for hospitalisation in patients with pneumonia
OBJECTIVES
1.Indications for hospitalisation and management
52
MANAGEMENT OF PNEUMONIA - PHARMACOLOGICAL THERAPY
SGD
PHARMACOLOGY
53
MANAGEMENT OF PNEUMONIA - HOSPITALISATION AND MANAGEMNT
LECTURE/SGD
54
SPUTUM EXAMINATION FOR AFB AND MANAGEMENT
DOAP
MICROBIOLOGY
Describe and enumerate the indications for isolation and barrier nursing in patients with
IM 3.16
pneumonia
OBJECTIVES
1.Indiactions for isolation
2.Indications for barrier nursing in pneumonia
Describe and discuss the supportive therapy in patients with pneumonia including oxygen
IM 3.17
use and indications for ventilation
OBJECTIVES
1.Indications for oxygen therapy
2.Indications for ventilation
55
ISOLATION AND BARRIER NURSING OF PNEUMONIA
LECTURE /SGD
56
OXYGEN THERAPY AND VENTILATION
LECTURE/SGD
ANESTHESIOLOGY
IM 3.18
Communicate and counsel patient on family on the diagnosis and therapy of pneumonia
OBJECTIVES
1.counselling for the patient's family on the diagnosis
2.Intimation regarding therapy
Discuss, describe, enumerate the indications and communicate to patients on
IM 3.19
pneumococcal and influenza vaccines
OBJECTIVES
1.Indications for pneumococcal vaccines
2.Indications for influenza vaccines
57
PNEUMONIA-VACCINATION AND COUNSELLING
SGD/DOAP
MICROBIOLOGY
TOPIC
FEVER AND FEBRILE SYNDROMES
Describe and discuss the febrile response and the influence of host immune status, risk
IM 4.1
factors and comorbidities on the febrile response
OBJECTIVES
1.Definition of febrile response
2.Host immune status and risk factors
3.Comorbidities in febrile reponse
Describe and discuss the influence of special populations on the febrile response
IM 4.2
including: the elderly, immune suppression, malignancy and neutropenia, HIV and travel
OBJECTIVES
1.Febrile response in elderly and immunosupressed
2.Febrile response in in malignancy and neutropenia
3.Febrilke response in HIV and travel
Elicit document and present a medical history that helps delineate the aetiology of fever
that includes the evolution and pattern of fever, associated symptoms, immune status,
comorbidities, risk factors, exposure through occupation, travel and environment and
IM 4.9
medication use
OBJECTIVES
1.History and pattern of fever
2.Risk factors and associated symptoms
FEVER - FEBRILE RESPONSE,HISTORY, RISKFACTORS ,IMMUNE STATUS AND ASSOCIATED
58
SYMPTOMS
LECTURE/SGD
MICROBIOLOGY
Discuss and describe the common causes, pathophysiology and manifestations of fever in
various regions in India including bacterial, parasitic and viral causes (e.g.Dengue,
IM 4.3
Chikungunya, Typhus)
OBJECTIVES
1. Comon causes of fever
2.Pathophysiology of fever
3.Manifestations of fever in various regions in India
Describe and discuss the pathophysiology and manifestations of inflammatory causes of
IM 4.4
fever
OBJECTIVES
1.Inflammatory causes of fever
2.Pathophysiology
Describe and discuss the pathophysiology and manifestations of malignant causes of fever
IM 4.5
including hematologic and lymph node malignancies
OBJECTIVES
1.Malignant cause of fever
2.Pathophysiology and manifestations
59
DENGUE FEVER
LECTURE
MICROBIOLOGY
60
CHIKUNGUNYA
LECTURE
MICROBIOLOGY
61
TYPHUS
LECTURE
MICROBIOLOGY
62
ENTERIC FEVER
LECTURE
MICROBIOLOGY
63
FEVER IN MALIGNANCIES
LECTURE
PATHOLOGY
IM 4.6
Discuss and describe the pathophysiology and manifestations of malaria
OBJECTIVES
1.PATHOPHYSIOLOGY
2.Clinical Manifestations of malaria
IM 4.7
Discuss and describe the pathophysiology and manifestations of the sepsis syndrome
OBJECTIVES
1. Clinical manifestations of sepsis syndrome
2.Various causes of sepsis
3.Pathophysiology
IM 4.15
Perform and interpret a malarial smear
OBJECTIVES
1.Preparartion of Malarial smear
2.Staining pattern
3.Identification of malarial parasite
Describe and discuss the pharmacology, indications, adverse reactions, interactions of
IM 4.22
antimalarial drugs and basis of resistance
OBJECTIVES
1. Indications and interaction of anti-malarial drugs
2.Adverse reactions
3.Drug resistance
Prescribe drugs for malaria based on the species identified, prevalence of drug
IM 4.23
resistance and national programs
OBJECTIVES
1.Drug therapy based on species identification
2.Prevalence of drug resistance in India
3.National malaria Programmes
IM 4.26
Counsel the patient on malarial prevention
OBJECTIVES
1.Counselling of malarial prevention
MALARIA - PATHOPHYSIOLOGY , CLINICAL FEATURES , MANAGEMENT AND NATIONAL
MICROBIOLOGY AND
64
PROGRAMMES
LECTURE
COMMUNITY MEDICINE
65
SEPSIS SYNDROME - MANIFESTATIONS AND MANAGEMENT
LECTURE
Discuss and describe the pathophysiology, aetiology and clinical manifestations of
fever of unknown origin (FUO) including in a normal host, neutropenic host,
IM 4.8
nosocomial host and a host with HIV disease
OBJECTIVES
1.Etiology and clinical manifestations of FUO
2.Pathophysiology of FUO
3. Various manifestations in special situations like nosocomial host/ HIV
66
FEVER OF UNKNOWN ORIGIN
LECTURE
Perform a systematic examination that establishes the diagnosis and severity of
presentation that includes: general skin mucosal and lymph node examination, chest and
IM 4.10
abdominal examination (including examination of the liver and spleen)
OBJECTIVES
1.General Examination/lymphnode
2.Systemic examination - chest,liver and spleen
Generate a differential diagnosis and prioritise based on clinical features that help
IM 4.11
distinguish between infective, inflammatory, malignant and rheumatologic causes
OBJECTIVES
1.Differential diagnosis of fever
2. Clinical features of various fevers
67
CLINICAL EXAMINATION AND DIFFERENTIAL DIAGNOSIS OF FEVER
SMALL GROUP DISCUSSION
Order and interpret diagnostic tests based on the differential diagnosis including: CBC
with differential, peripheral smear, urinary analysis with sediment, Chest X ray, blood and
urine cultures, sputum gram stain and cultures, sputum AFB and cultures, CSF analysis,
IM 4.12pleural and body fluid analysis, stool routine and culture and QBC
OBJECTIVES
1.CBC,peripheral smear study
2.Urine analysis
3.Chest X-ray
4.Blood and urine cultures
5.AFB,Gram stain culture
6.CSF analysis and culture
7.Pleural fluid analysis and culture
8.Stool routine and culture
IM 4.13
Perform and interpret a sputum gram stain
OBJECTIVES
1.Preparation of sputum smear gram staining
2.Interpretation
IM 4.14
Perform and interpret a sputum AFB
OBJECTIVES
1.Preparation of sputum AFB technique
2.Interpretation of sputum AFB
68
INVESTIGATIONS BASED ON DIFFERENTIAL DIAGNOSIS IN FEVER
LECTURE
Enumerate the indications and describe the findings in tests of inflammation and
specific rheumatologic tests, serologic testing for pathogens including HIV, bone
IM 4.16
marrow aspiration and biopsy
OBJECTIVES
1.Specific serology for HIV
2.Specific testing for Rheumatological disease,bone marrow biopsy and culture
Observe and assist in the performance of a bone marrow aspiration and biopsy in
IM 4.17
a simulated environment
OBJECTIVES
1.Preparation of bone marrow aspirations
2.Indications and contra-indications
3.Observe bone marrow biopsy procedure
Enumerate the indications for use of imaging in the diagnosis of febrile syndromes
IM 4.18
OBJECTIVES
1.Imaging modalities like USG,CT/MRI Brain and spine
IM 4.19
Assist in the collection of blood and wound cultures
OBJECTIVES
1.Collection of blood sample and wound secretions for culture
IM 4.20
Interpret a PPD (Mantoux)
OBJECTIVES
1. Indications for mantoux
2.Interpretation of mantoux
69
SPECIAL INVESTIGATIONS AND IMAGING IN FEVER
LECTURE/SGD
RADIOLOGY
Develop and present an appropriate diagnostic plan based on the clinical
IM 4.21
presentation, most likely diagnosis in a prioritised and cost effective manner
OBJECTIVES
1.Diagnosis based on clinical findings and investigations
2. Cost effective management
IM 4.25
Communicate to the patient and family the diagnosis and treatment
OBJECTIVES
1.Communication regarding the disease to family
2. Treatment plan and prognosis
70
TREATMENT PLAN AND COUNSELLING TO THE FAMILY
SMALL GROUP DISCUSSION
LIVER DISEASES
IM 5.1
Describe and discuss the physiologic and biochemical basis of hyperbilirubinemia
OBJECTIVES
1. Physiological changes in hyperbilirubenemia
2. biological basis of hyperbilirubenemia
IM 5.2
Describe and discuss the aetiology and pathophysiology of liver injury
OBJECTIVES
1. Etiology of liver injury
2. Pathophysiology of liver injury
IM 5.3
Describe and discuss the pathologic changes in various forms of liver disease
OBJECTIVES
1. Pathological changes of liver diseases
2. various forms of liver diseases
IM 5.7
Enumerate and describe the causes and pathophysiology of drug induced liver injury
OBJECTIVES
1. Causes of liver injury
2. Drugs that causes liver injury
3. Pathophysiology of drug induced liver injury
BIOCHEMISTRY/PHYSIOL
71
LIVER FUNCTIONS AND BIOCHEMICAL CHANGES IN LIVER INJURY
LECTURE/SGD
OGY
72
PATHOPHYSIOLOGY OF LIVER INJURY
LECTURE/SGD
PATHOLOGY
73
ETIOLOGY , PATHOPHYSIOLOGY OF DRUG INDUCED LIVER DISEASE
LECTURE/SGD
Pharmacology
Describe and discuss the epidemiology, microbiology, immunology and clinical
IM 5.4
evolution of infective (viral) hepatitis
OBJECTIVES
1. Epidemiology of viral hepatitis
2. Microbiology and immunology
3. Clinical evaluation
Choose and interpret appropriate diagnostic tests including: CBC, bilirubin,
function tests, Hepatitis serology and ascitic fluid examination in patient with liver
IM 5.12
diseases
OBJECTIVES
1. Blood investigations, liver function test, CBC, hepatitis serology
2. Viral markers
3. Ascitic fluid examination
74
INFECTIVE HEPATITIS, CLINICAL EVALUATION AND INVESTIGATIONS
LECTURE
MICROBIOLOGY
Describe and discuss the pathophysiology and clinical evolution of alcoholic liver
IM 5.5
disease
OBJECTIVES
1. Pathophysiology
2. Clinical evaluation of alcholic liver disease
Describe and discuss the pathophysiology, clinical evolution and complications of
cirrhosis and portal hypertension including ascites, spontaneous bacterial
IM 5.6
peritonitis, hepatorenal syndrome and hepatic encephalopathy
OBJECTIVES
1. Etiopathogenesis of cirrhosis
2. Complications of cirrhosis
3. Clinical evaluation
Elicit document and present a medical history that helps delineate the aetiology of
the current presentation and includes clinical presentation, risk factors, drug use,
IM 5.9
sexual history, vaccination history and family history
OBJECTIVES
1. Medical history and etiology
2. Risk factors
3. History of drug exposure, sexual history, vaccination history and family history
Perform a systematic examination that establishes the diagnosis and severity that
includes nutritional status, mental status, jaundice, abdominal distension ascites,
IM 5.10
features of portosystemic hypertension and hepatic encephalopathy
OBJECTIVES
1. Systemic examination of the abdomen
2. Physical signs of portosystemic hypertension, hepatic encephalopathy
3. Mental status, jaundice and nutritional status
Generate a differential diagnosis and prioritise based on clinical features that
IM 5.11
suggest a specific aetiology for the presenting symptom
OBJECTIVES
1. Differential diagnosis specific to etiology and symptoms
75
ALCOHOLIC LIVER DISEASE - PATHOPHYSIOLOGY
LECTURE /SGD
76
CIRRHOSIS OF LIVER - CLINICAL PRESENTATION AND IT'S COMPLICATIONS
LECTURE/SGD
Describe and discuss the pathophysiology, clinical evolution and complications
IM 5.8
cholelithiasis and cholecystitis
OBJECTIVES
1. Pathophysiology
2. Clinical presentation
3. Complications
77
CHOLELOLITHIASIS AND CHOLECYSTITIS
LECTURE /SGD
GENERAL SURGERY
Enumerate the indications for ultrasound and other imaging studies including
IM 5.13
MRCP and ERCP and describe the findings in liver disease
OBJECTIVES
1. Indications for ultrasound
2. Indications for MRCP, ERCP
Outline a diagnostic approach to liver disease based on hyperbilirubinemia, liver
IM 5.14
function changes and hepatitis serology
OBJECTIVES
1. LFT Interpretation
2. Hepatitis serology interpretation
IM 5.15
Assist in the performance and interpret the findings of an ascitic fluid analysis
OBJECTIVES
1. Ascitic fluid analysis - indications and demonstration
2. Interpretation of ascitic fluid analysis
78
INVESTIGATIONS OF LIVER DISEASE
SGD
RADIODIAGNOSIS
Describe and discuss the management of hepatitis, cirrhosis, portal hypertension,
IM 5.16
ascites spontaneous, bacterial peritonitis and hepatic encephalopathy
OBJECTIVES
1. Management of liver cell injury and hepatitis
1. Management of cirrhosis of liver
2. Management of portal hypertension and it's complications
79
MANAGEMENT OF LIVER CELL INJURY AND HEPATITIS
LECTURE
80
MANAGEMENT OF CIRRHOSIS AND IT'S COMPLICATIONS
LECTURE
PHARMACOLOGY
Enumerate the indications, precautions and counsel patients on vaccination for
IM 5.17
hepatitis
OBJECTIVES
1. Indications of hepatitis vaccination
2. Precautions and counselling
IM 5.18
Enumerate the indications for hepatic transplantation
OBJECTIVES
1. Indications of liver transplant
81
HEPATITIS VACCINATION
LECTURE/SGD
MICROBIOLOGY
82
LIVER TRANSPLANTATION
LECTURE/SGD
TOPIC
HIV
IM 6.1
Describe and discuss the symptoms and signs of acute HIV seroconversion
OBJECTIVES
1.Symptoms and signs of acute HIV
2.seroconversion of HIV
IM 6.2
Define and classify HIV AIDS based on the CDC criteria
OBJECTIVES
1.Defininition of HIV-AIDS
2.Classification of HIV AIDS based on CDC CRITERIA
83
DEFINITION OF HIV AND CLASSIFICATION
LECTURE/SGD
Describe and discuss the relationship between CDC count and the risk of opportunistic
IM 6.3
infections
OBJECTIVES
1.CDC count and risk of oppurtunistic infection
2.Types of oppurtunistic infections
Describe and discuss the pathogenesis, evolution and clinical features of common HIV
IM 6.4
related opportunistic infections
OBJECTIVES
1.Pathogenesis of oppurtunistic infections
2.Clinical features of oppurtunistic infections
84
HIV AND OPPURTUNISTIC INFECTIONS
LECTURE/SGD
MICROBIOLOGY
Describe and discuss the pathogenesis, evolution and clinical features of common HIV
IM 6.5
related malignancies
OBJECTIVES
1.Pathogenesis of HIV related Malignancies
2.Clinical features of HIV related Malignancies
4.severity of pneumonia
85
HIV AND MALIGNANCIES
LECTURE /SGD
PATHOLOGY
Describe and discuss the pathogenesis, evolution and clinical features of common HIV
IM 6.6
related skin and oral lesions
OBJECTIVES
1.Pathogenesis of HIV related Skin diseases
2.Clinical features of Skin and Oral lesions
86
HIV - SKIN AND ORAL DISEASES
LECTURE/SGD
DERMATOLOGY
Elicit document and present a medical history that helps delineate the aetiology of the
current presentation and includes risk factors for HIV, mode of infection, other sexually
IM 6.7
transmitted diseases, risks for opportunistic infections and nutritional status
OBJECTIVES
1.Medical history elicitation
2.Etiology
3.Risk factors
4.Mode of transmission
5.Opportunistic infection and nutritional status
Generate a differential diagnosis and prioritise based on clinical features that suggest a
IM 6.8
specific aetiology for the presenting symptom
OBJECTIVES
1.Differential diagnosis based on symotoms and clinical features
87
HIV-HISTORY,ETIOLOGY,CLINICAL FEATURES,MODE OF TRANSMISSION/DD
SGD/DOAP
Choose and interpret appropriate diagnostic tests to diagnose and classify the severity of
IM 6.9
HIV-AIDS including specific tests of HIV, CDC
OBJECTIVES
1.HIV specific test
Choose and interpret appropriate diagnostic tests to diagnose opportunistic infections
including CBC, sputum examination and cultures, blood cultures, stool analysis, CSF
IM 6.10
analysis and Chest radiographs
OBJECTIVES
1.Blood Investigations-CBC,Blood culture
2.Sputum examination-Culture,AFB
3.CSF analysis and culture
4.Chest X-ray
5.Stool examination
IM 6.11
Enumerate the indications and describe the findings for CT of the chest and brain and MRI
OBJECTIVES
1.Indication for CT-Brain/Chest and MRI
Enumerate the indications for and interpret the results of: pulse oximetry, ABG, Chest
IM 6.12
Radiograph
OBJECTIVES
1.Indication for ABG, chest X-Ray
2.Interpretation of pulsoxymetry
IM 6.14
Perform and interpret AFB sputum
OBJECTIVES
1.Sputum,staining for AFB and interpretation
88
HIV INVESTIGATIONS
SGD/DOAP
MICROBIOLOGY
Describe and enumerate the indications and side effects of drugs for bacterial, viral and
IM 6.13
other types of diarrhea
OBJECTIVES
1.Types of diarrheoa
2.Indications and side effects of the drugs for diarrheoa
89
HIV AND DIARRHOEAL DISEASE
LECTURE/SGD
OBJECTIVES
1.Indications for hospitalisation and management
IM 6.15
Demonstrate in a model the correct technique to perform a lumbar puncture
OBJECTIVES
1.Indiactions for lumbar puncture
2.Diagnostic use of CSF analysis in HIV
90
HIV - CSF EXAMINATION
DOAP
Discuss and describe the principles of HAART, the classes of antiretrovirals used, adverse
IM 6.16
reactions and interactions
OBJECTIVES
1 Principles of HAART
2.Anti-retroviral drugs
3.Drug adverse reaction and interactions
IM 6.17
Discuss and describe the principles and regimens used in post exposure prophylaxis
OBJECTIVES
1.Post- exposure prophylaxis regimens
2.Principles of drug regime
Enumerate the indications and discuss prophylactic drugs used to prevent HIV related
IM 6.18
opportunistic infections
OBJECTIVES
1.Prophylactic drugs to prevent opportunistic infections
91
HIV - MANAGEMENT
LECTURE/SGD
PHARMACOLOGY
IM 6.19
Counsel patients on prevention of HIV transmission
OBJECTIVES
1.Counselling the patient for HIV transmission prevention
2.Explaining the importance of prevention of the disease
IM 6.20
Communicate diagnosis, treatment plan and subsequent follow up plan to patients
OBJECTIVES
1.Explaing the importance of the treatment plan
2.Importance of follow up to control the infection
IM 6.21
Communicate with patients on the importance of medication adherence
OBJECTIVES
1.Explaing the importance of taking regular medications
92
COUNSELLING TO THE HIV PATIENT AND FOLLOW UP THERAPY
DOAP
AETCOM
Demonstrate understanding of ethical and legal issues regarding patient confidentiality
IM 6.22
and disclosure in patients with HIV
OBJECTIVES
1.Explaining the ethical issues
2.Creating awarness for legal issues regarding patient's confidentiality
IM 6.23
Demonstrate a non-judgemental attitude to patients with HIV and to their lifestyles
OBJECTIVES
1.Demonstrating the life style of the patient
2.Non-judgemental attitude to patients
93
HIV-ETHICAL AND LEGAL ISSUES AND CREATING AWARENESS OF LIFESTYLE
SGD/DOAP
AETCOM
TOPIC
RHEUMATOLOGICAL PROBLEMS
IM 7.1
Describe the pathophysiology of autoimmune disease
OBJECTIVES
1.Pathophysiology of autoimmune disease
IM 7.2
Describe the genetic basis of autoimmune disease
OBJECTIVES
1.Genetic basis of autoimmune disease
94
AUTO-IMMUNE DISEASE - PATHOPHYSIOLOGY AND GENETIC BASIS
LECTURE
PATHOLOGY
IM 7.3
Classify cause of joint pain based on the pathophysiology
OBJECTIVES
1. Pathophysiological Causes of joint pain
IM 7.4
Develop a systematic clinical approach to joint pain based on the pathophysiology
OBJECTIVES
1.Clinical approach to joint pain
IM 7.5
Describe and discriminate acute, subacute and chronic causes of joint pain
OBJECTIVES
1.Types of joint pain
2.Various causes of joint pain
95
JOINT PAIN - CAUSES ,TYPES AND SYSTEMATIC CLINICAL APPROACH
LECTURE/SGD
Discriminate, describe and discuss arthralgia from arthritis and mechanical from
IM 7.6
inflammatory causes of joint pain
OBJECTIVES
1.Difference between arthralgia and arthritis
2.Mechanical and inflammatory causes of joint pain
IM 7.7
Discriminate, describe and discuss distinguishing articular from periarticular complaints
OBJECTIVES
1. Difference between articular and periarticular complaints
Determine the potential causes of join pain based on the presenting features of joint
IM 7.8
involvement
OBJECTIVES
1.Causes of Joint pain based on joint involvement
2.Arthritis and
3.Arthralgia and
4.Joint pain
96
RHEUMATOLOGICAL DISEASE- ARTHRITIS,ARTHRALGIA AND JOINT PAIN
LECTURE
ORTHOPAEDICS
IM 7.9
Describe the common signs and symptoms of articular and periarticular diseases
OBJECTIVES
1.Signs ad symptoms in articular diseases
2.Signs and symptoms in periarticular diseases
IM 7.10
Describe the systemic manifestations of rheumatologic disease
OBJECTIVES
1.Systemic manifestations in Rheumatology
2.SLE - Definition, Etiology, pathogenesis and systematic manifestations
3.Rheumatoid arthritis- Definition, Etiology, pathogenesis and systematic manifestations
4.Osteoposrosis- Definition, Etiology, pathogenesis and systematic manifestations
5.Seronegative arthritis - Definition, Etiology, pathogenesis and systematic manifestations
6.Ankylosing spondylitis - Definition, Etiology, pathogenesis and systematic manifestations
7.Systemic sclerosis- Definition, Etiology, pathogenesis and systematic manifestations
8.Sjogren's syndrome and Mixed Connective Tissue Disorder - Definition, Etiology,
pathogenesis and systematic manifestations
9.Polymyositis and dermatomyositis - Definition, Etiology, pathogenesis and systematic
manifestations
10.Osteomalacia and rickets - Definition, Etiology, pathogenesis and manifestations
97
SYSTEMIC LUPUS ERTHYEMATOSUS
LECTURE
98
RHEUMATOID ARTHRITIS
LECTURE
99
OSTEOPOROSIS
LECTURE
ORTHOPAEDICS
100
SERO NEGATIVE ARTHRITIS
LECTURE
101
ANKYLOSING SPONDYLITIS
LECTURE
102
SYSTEMIC SCLEROSIS
LECTURE
103
SJOGREN'S SYNDROME
LECTURE
104
POLYMYOSITIS AND DERMATOMYOSITIS
LECTURE
105
OSTEOMALACIA AND RICKETS
LECTURE
Elicit document and present a medical history that will differentiate the aetiologies of
IM 7.11
disease
OBJECTIVES
1.History to differentiate Rheumatological diseaseS
Perform a systematic examination of all joints, muscle and skin that will establish the
IM 7.12
diagnosis and severity of disease
OBJECTIVES
1.Examination of skin in rheumatology
2.Examination of muscle and all joints for diagnosis
106
RHEUMATOLOGICAL DISEASE - HISTORY AND CLINICAL EXAMINATION
SMALL GROUP DISCUSSION
Generate a differential diagnosis and prioritise based on clinical features that suggest a
IM 7.13
specific aetiology
OBJECTIVES
1.Differential diagnosis based on clinical features
IM 7.14
Describe the appropriate diagnostic work up based on the presumed aetiology
OBJECTIVES
1.Diagnostic plan based on etiology
107
RHEUMATOLOGICAL DISEASE - DIFFERENTIAL DIAGNOSIS AND DIAGNOSTIC PLAN
LECTURE/SGD
Enumerate the indications for and interpret the results of : CBC, anti- CCP, RA, ANA, DNA
IM 7.15
and other tests of autoimmunity
OBJECTIVES
1.Indications for tests in Rheumatology
2.Interpretation of test results
IM 7.16
Enumerate the indications for arthrocentesis
OBJECTIVES
1. Indications of arthrocentesis
2.Arthrocentesis procedure
IM 7.17
Enumerate the indications and interpret plain radiographs of joints
OBJECTIVES
1.Indications for Xray joints
2.Interpretation of Xrays
PATHOLOGY AND
108
RHEUMATOLOGICAL DISEASES- INVESTIGATIONS
LECTURE
RADIOLOGY
IM 7.18
Communicate diagnosis, treatment plan and subsequent follow up plan to patients
OBJECTIVES
1.Diagnosis and treatment plan
2.Communication of the plan to patients
IM 7.19
Develop an appropriate treatment plan for patients with rheumatologic diseases
OBJECTIVES
1.Treatment plan for diseases
IM 7.20
Select, prescribe and communicate appropriate medications for relief of joint pain
OBJECTIVES
1.Selection of appropriate medications for joint pain
2. Prescription and proper communication
IM 7.21
Select, prescribe and communicate preventive therapy for crystalline arthropathies
OBJECTIVES
1.Selection of preventive therapy for crystalline arthropathies
2.Prescription and proper communication
Select, prescribe and communicate treatment option for systemic rheumatologic
IM 7.22
conditions
OBJECTIVES
1.Selection of drug therapy for systemic rheumatologic conditions
2.Prescription and proper communication
Describe the basis for biologic and disease modifying therapy in rheumatologic
IM 7.23
diseases
OBJECTIVES
1.Basis of Biologic therpay in rheumatology
2.Basis of DMARDS
IM 7.24
Communicate and incorporate patient preferences in the choice of therapy
OBJECTIVES
1.Incorporating patients preferance in choice of therapy
109
TREATMENT PLAN AND DRUG THERAPY IN RHEUMATOLOGICAL DISEASES
LECTURE
PHARMACOLOGY
Develop and communicate appropriate follow up and monitoring plans for patients
IM 7.25
with rheumatologic conditions
OBJECTIVES
1.Develop follow up and monitoring plan for Rheumatological conditions
2.Communicate the plan with patients
Demonstrate an understanding of the impact of rheumatologic conditions on quality of
IM 7.26
life, well being, work and family
OBJECTIVES
1.Impact of disease on quality of life
2. Counsel the patients
IM 7.27
Determine the need for specialist consultation
OBJECTIVES
1.To Determine the need for specialist consultation
110
RHEUMATOLOGICAL DISEASES- FOLLOW UP,COUNSELLING AND REHABILITATION
LECTURE
TOPIC
HYPERTENSION
Describe and discuss the epidemiology, aetiology and the prevalence of primary
IM 8.1
and secondary hypertension
OBJECTIVES
1. Primary / Secondary Hyper tension Epidemiology
2. Aetiology of Hyper tension
3. Prevalence of Hyper tension
IM 8.2
Describe and discuss the pathophysiology of hypertension
OBJECTIVES
Pathophysiology of hypertension
IM 8.3
Describe and discuss the genetic basis of hypertension
OBJECTIVES
Genetic basis of hypertension
PATHOLOGY AND
111
HYPERTENSION - EPIDEMIOLOGY, PATHO PHYSIOLOGY, GENETIC BASIS
LECTURE/SGD
PHYSIOLOGY
IM 8.4
Define and classify hypertension
OBJECTIVES
1. Definition of hypertension
2. Classification of hypertension
Describe and discuss the differences between primary and secondary hypertension
IM 8.5
OBJECTIVES
1. Difference between primary and secondary hypertension
HYPERTENSION CLASSIFICATION, DIFFERENCE BETWEEN PRIMARY AND SECONDARY
112
HYPERTENSION
LECTURE/SGD
PATHOLOGY
Define, describe and discuss and recognise hypertensive urgency and emergency
IM8.6
OBJECTIVES
1. Emergencies of uncontrolled hypertension
2. Urgency of uncontrolled hypertension
IM8.8
Describe, discuss and identify target organ damage due to hypertension
OBJECTIVES
1. Identify target organ damage
2. Etiopatho genis
Describe and discuss the clinical manifestations of the various aetiologies of
IM 8.7
secondary causes of hypertension
OBJECTIVES
1. Aetiologies of secondary hypertension
2. Clinical Presentation
113
HYPERTENSIVE EMERGENCY , URGENCY AND SECONDARY HYPERTENSION
LECTURE/SGD
PATHOLOGY
Elicit document and present a medical history that includes: duration and levels,
symptoms, comorbidities, lifestyle, risk factors, family history, psychosocial and
environmental factors, dietary assessment, previous and concomitant therapy
IM8.9
OBJECTIVES
1. History of hypertension
2. Symptoms of hypertension
3. Risk factors of hypertension
4. Comorbidities of hypertension
5. Dietary Assessment
Perform a systematic examination that includes : an accurate measurement of
blood pressure, fundus examination, examination of vasculature and heart
IM 8.10
OBJECTIVES
1. Measurement of blood pressure
2. Physical Examination of Vascular System and Heart
3. Fundus examination
Generate a differential diagnosis and prioritise based on clinical features that
IM 8.11
suggest a specific aetiology
OBJECTIVES
1. Differential diagnosis of hypertension
2. Specific Aetiology for DD
HYPERTENSION-HISTORY , RISK FACTORS, CLINICAL FEATURES AND DIFFERNTIAL
114
DIAGNOSIS .
LECTURE/SGD
Describe the appropriate diagnostic work up based on the presumed aetiology
IM 8.12
OBJECTIVES
1. Investigation based on aetiology
Enumerate the indications for and interpret the results of : CBC, Urine routine,
IM 8.13
BUN, Cr, Electrolytes, Uric acid, ECG
OBJECTIVES
1. Blood investigation - CBC, BUN, Cr, Electrolytes, Uric acid
2. ECG - Recording and interpretation
3. Urine Routine
IM 8.17
Perform and interpret a 12 lead ECG
Objective:
1. ECG - Recording and interpretation
115
HYPERTENSION - INVESTIGATIONS
SGD
IM 8.14
Develop an appropriate treatment plan for essential hypertension
OBJECTIVES
1. Treatment plan for Primary Hypertension
2. Drug therapy and dieatry advice
IM 8.15
Recognise, prioritise and manage hypertensive emergencies
OBJECTIVES
1. Hypertensive emergency - effective Management
Develop and communicate to the patient lifestyle modification including weight
reduction, moderation of alcohol intake, physical activity and sodium intake
IM 8.16
OBJECTIVES
1. Life style modification - weight reduction, moderate alchohol intake
2. Increasing physical activity, decrease sodium intake
IM 8.17
Incorporate patient preferences in the management of HTN
OBJECTIVES
1. Priority and preferrences in treatment of hypertension
116
HYPERTENSION MANAGEMENT
LECTURE
PHARMACOLOGY
Demonstrate understanding of the impact of Hypertension on quality of life, well
IM 8.19
being, work and family
OBJECTIVES
1. Impact of Hypertension on quality of life
2. Importance of following drug therapy and advise to the family
IM 8.20
Determine the need for specialist consultation
OBJECTIVES
1. Importance of specialist consultation
2. To reduce morbidity and mortality
HYPERTENSION ADVISE TO REDUCE MORBIDITY AND MORTALITY
117
DOAP/SGD
TOPIC
ANEMIAS
Define, describe and classify anemia based on red blood cell size and reticulocyte
IM9.1
count
OBJECTIVES
1.Definition for anemia
2.Classification based on morphology of RBC and reticulocyte
Describe and discuss the morphological characteristics, aetiology and prevalence
IM9.2
of each of the causes of anemia
OBJECTIVES
1.Description of morphology of blood cells
2.Etiological classification of anemia
3.Nutritional deficiency anemias - Etiology and pathogenesis
4.Hemoglobinopathies and Hemolytic anemias - Etiology and pathogenesis
5.Anemia of blood loss -Etiology and pathogenesis
Elicit document and present a medical history that includes symptoms, risk factors
including GI bleeding, prior history, medications, menstrual history, and family
IM9.3
history
OBJECTIVES
1.Medical history relate to anemia
2.Symptom analysis and risk factors
Perform a systematic examination that includes : general examination for pallor,
oral examination, DOAP session of hyper dynamic circulation, lymph node and
IM9.4
splenic examination
OBJECTIVES
1.General Physical examination
2.Examination of abdomen and lymphnodes and abdomen
Generate a differential diagnosis and prioritise based on clinical features that
IM9.5
suggest a specific aetiology
OBJECTIVES
1.Clinical features based on etiology
2.Differential diagnosis
118
ANEMIA - CLASSIFICATION , ETIOLOGY AND HISTORY
LECTURE/DOAP
ANEMIA - HISTORY,PHYSICAL EXAMINATION AND DIFFERENTIAL
119
SGD/DOAP
120
NUTRITIONAL ANEMIAS - IRON DEFICIENCY ANEMIA
LECTURE/DOAP
PATHOLOGY
121
NUTRITIONAL ANEMIAS - MEGALOBLASTIC ANEMIA
LECTURE/DOAP
PATHOLOGY
122
HEMOGLOBINOPATHIES
LECTURE/DOAP
PATHOLOGY
123
HEMOLYTIC ANEMIA
LECTURE/DOAP
PATHOLOGY
124
SECONDARY ANEMIAS
LECTURE/DOAP
PATHOLOGY
Describe the appropriate diagnostic work up based on the presumed aetiology
IM9.6
OBJECTIVES
1.Diagnostic plan based on etiology
Describe and discuss the meaning and utility of various components of the
IM9.7
hemogram
OBJECTIVES
1.interpretation of peripheral blood smear study
Describe and discuss the various tests for iron deficiency
IM9.8
OBJECTIVES
1.Biochemical analysis - serum iron,serum ferritin,TIBC
2.Peripheral blood smear
Order and interpret tests for anemia including hemogram, red cell indices,
IM9.9
reticulocyte count, iron studies, B12 and folate
OBJECTIVES
1.Hematological indices interpretation
2.Iron,B12 and folate assay
Describe, perform and interpret a peripheral smear and stool occult blood
IM9.10
OBJECTIVES
1.Preparation of peripheral blood smear
2.PS study and interpretation
3.Stool examination for occult blood
Describe the indications and interpret the results of a bone marrow aspirations and
IM9.11
biopsy
OBJECTIVES
1.Indicattions and contraindications for bone marrow study
2.Permforming bone marrow biopsy
3.Interpretation of bone marrow study
IM9.12
Describe, develop a diagnostic plan to determine the aetiology of anemia
OBJECTIVES
1.Diagnostic plan based on etiology
ANEMIA INVESTIGATIONS- HEMOGRAM, AND PERIPHERAL BLOOD SMEAR
PATHOLOGY
125
LECTURE /DOAP
/BIOCHEMISTRY
126
BONE MARROW BIOPSY
LECTURE /DOAP
PATHOLOGY
ANEMIA INVESTIGATIONS - SPECIAL INVESTIGATIONS BASED ON
ETIOLOGY
127
LECTURE /DOAP
BIOCHEMISTRY
IM9.13
Prescribe replacement therapy with iron, B12, folate
OBJECTIVES
1.Iron replacement therapy
2.B12 and folate replacement therapy
IM9.14
Describe the national programs for anemia prevention
OBJECTIVES
1.National anemia programmes
IM9.15
Communicate the diagnosis and the treatment appropriately to patients
OBJECTIVES
1.Counsel the patient regarding diagnosis
2.Counsel the patient regarding therapy
IM9.16
Incorporate patient preferences in the management of anemia
OBJECTIVES
1.Incorporating patients preferance in therapy
NUTRITIONAL DEFICIENCY ANEMIA- MANAGEMENT AND NATIONAL
128
ANEMIA PROGRAMMES
LECTURE
COMMUNITY MEDICINE
Describe the indications for blood transfusion and the appropriate use of blood
IM9.17
components
OBJECTIVES
1.Indications for blood transfusion
2.Componenets of blood transfusion
Describe the precautions required necessary when performing a blood transfusion
IM9.18
OBJECTIVES
1.Preparation of the patient for blood transfusion
2.Observation of Tranfusion reactions
IM9.19
Assist in a blood transfusion
OBJECTIVES
1.Monitoring the vitals
2.Maintenance of blood transfusion chart
129
ANEMIA - BLOOD COMPONENTS TRANSFUSION
LECTURE
PATHOLOGY
Communicate and counsel patients with methods to prevent nutritional anemia
IM9.20
OBJECTIVES
1.Counselling to correct nutritional anemia
2.Dietary advice
3.Personal hygiene
IM9.21
Determine the need for specialist consultation
OBJECTIVES
1.Early detection of anemia to prevent complications
2.Management of complicated anemia
COUNSELLING FOR CORRECTION OF NUTRITIONAL ANEMIA AND SPECIALIST
130
CONSULTATION
DOAP
TOPIC
Acute Kidney Injury and Chronic renal failure
IM 10.1
Define, describe and differentiate between acute and chronic renal failure
OBJECTIVES
1.Definition of renal failure
2.Difference between acute and chronic renal failure
IM 10.2
Classify, describe and differentiate the pathophysiologic causes of acute renal failure
OBJECTIVES
1.Classification of acute renal failure(ARF)
2.Pathophysiology
3.Causes
IM 10.3
Describe the pathophysiology and causes of pre renal ARF, renal and post renal ARF
OBJECTIVES
1.Pathophysiology of Pre-Renal,Renal,Post-Renal ARF
2.Causes of Pre-Renal,Renal,Post-Renal ARF
IM 10.4
Describe the evolution, natural history and treatment of ARF
OBJECTIVES
1.History of ARF
2.Evolution of Renal failure
3.Treatment of ARF
ACUTE RENAL FAILURE - ETIOPATHOGENESIS,CLASSIFICATION AND CLINICAL
131
PRESENTATION
LECTURE/SGD
PATHOLOGY
132
ACUTE RENAL FAILURE - MANAGEMENT
LECTURE/SGD
IM 10.5
Describe and discuss the aetiology of CRF
OBJECTIVES
1.Etiology of Chronic Renal Failure
IM 10.6
Stage Chronic Kidney Disease
OBJECTIVES
1.Various satges of chronic renal failure
IM 10.7
Describe and discuss the pathophysiology and clinical findings of uraemia
OBJECTIVES
1.Pathophysiology of Chronic renal failure
2.Clinical findings of CRF
IM 10.8
Classify, describe and discuss the significance of proteinuria in CKD
OBJECTIVES
1.Classification of proteinurea in CKD
2.Significance of proteinurea in CKD
133
CHRONIC RENAL FAILURE- ETIOPATHOGENESIS,STAGING AND UREMIA
LECTURE/SGD
PATHOLOGY
134
CHRONIC RENAL FAILURE AND PROTEINURIA
LECTURE/SGD
PATHOLOGY
IM 10.9
Describe and discuss the pathophysiology of anemia and hyperparathyroidism in CKD
OBJECTIVES
1.Pathophysiology of anemia in CKD
2.Hyperparathyroidism in CKD
IM 10.10
Describe and discuss the association between CKD glycemia and hypertension
OBJECTIVES
1.Hypertension in CKD
2.GlyCemia in CKD
IM 10.11
Describe and discuss the relationship between CAD risk factors and CKD and in dialysis
OBJECTIVES
1.CAD risk factors in CKD
2.CAD riskfactors in Dialysis
135
ANEMIA AND HYPERPARATHYROIDISM IN CKD
LECTURE
136
HYPERTENSION AND HYPERGLYCEMIA IN CKD
LECTURE
137
CAD RISK FACTORS IN CKD IN DIALYSIS
LECTURE/SGD
Elicit document and present a medical history that will differentiate the aetiologies of
disease, distinguish acute and chronic disease, identify predisposing conditions,
IM 10.12
nephrotoxic drugs and systemic causes
OBJECTIVES
1.Medical History for etiology
2.Difference between acute and chronic renal failure
3.Predisposing factors-nephrotoxic drugs and systemic diseases
Perform a systematic examination that establishes the diagnosis and severity including
determination of volume status, presence of edema and heart failure, features of uraemia
IM 10.13
and associated systemic disease
OBJECTIVES
1.Physical examination for establishing the diagnosis
2.To assess the severity of the disease
3.Determination of volume status-edema , cardiac failure
4.Features of uremia
Generate a differential diagnosis and prioritise based on clinical features that suggest a
IM 10.14
specific aetiology
OBJECTIVES
1.Clinical features specific to the etiology
2.Differential diagnosis
138
SYSTEMIC DISEASES AND NEPHROTOXIC DRUGS IN CKD
LECTURE/SGD
139
CRF CLINICAL PRESENTATION,PREDISPOSING CONDITIONS,DIFFENTIAL DIAGNOSIS
LECTURE/SGD
IM 10.15
Describe the appropriate diagnostic work up based on the presumed aetiology
OBJECTIVES
1.Diagnostic workup based on etiology
Enumerate the indications for and interpret the results of : renal function tests, calcium,
IM 10.16
phosphorus, PTH, urine electrolytes, osmolality, Anion gap
OBJECTIVES
1.Indications for renal function test
2.Interpretation of calcium, phosphorus,PTH,serum electrolytes,anion gap
3.Urine osmolality
Describe and calculate indices of renal function based on available laboratories including
IM 10.17
FENa (Fractional Excretion of Sodium) and CrCl (Creatinine Clearance)
OBJECTIVES
1.Interpretation of FENa
2.Interpretation of creatinine clearence
IM 10.18
Identify the ECG findings in hyperkalemia
OBJECTIVES
1.ECG-hyperkalemia chages-tall T waves
IM 10.19
Enumerate the indications and describe the findings in renal ultrasound
OBJECTIVES
1.Indication for USG- KUB area
2.To assess the kidney size
Describe and discuss the indications to perform arterial blood gas analysis: interpret the
IM 10.20
data
OBJECTIVES
1.Indication to perform ABG analysis
2.Interpretation of ABG
140
RENAL FAILURE- HEMATOLOGICAL INVESTIGATIONS
SGD
PATHOLOGY
141
RENAL FAILURE- NON-INVASIVE AND SPECIAL INVESTIGATIONS
SGD
RADIOLOGY
142
KIDNEY BIOPSY AND ITS INTERPRETATION
DOAP
IM 10.21
Describe and discuss the indications for and insert a peripheral intravenous catheter
OBJECTIVES
1.Indications for Peripheral venous catheter
Describe and discuss the indications, demonstrate in a model and assist in the insertion of
IM 10.22
a central venous or a dialysis catheter
OBJECTIVES
1.Indications for insertion of Central venous catheter
IM 10.23
Communicate diagnosis treatment plan and subsequent follow up plan to patients
OBJECTIVES
1.Councelling for diagnosis and treatment plan
2.Councelling for followup plan
IM 10.24
Counsel patients on a renal diet
OBJECTIVES
1.Councelling for Renal diet
Identify and describe the priorities in the management of ARF including diet, volume
IM 10.25
management, alteration in doses of drugs, monitoring and indications for dialysis
OBJECTIVES
1.Diet,fluid and drugs management in ARF
2.Indications for dialysis
Describe and discuss supportive therapy in CKD including diet, anti hypertensives,
glycemic therapy, dyslipidemia, anemia, hyperkalemia, hyperphosphatemia and
IM 10.26
secondary hyperparathyroidism
OBJECTIVES
1.Diet,drugs,and supportuve therapy in CKD
IM 10.27
Describe and discuss the indications for renal dialysis
OBJECTIVES
1.Indication of renal dialysis and types of renal dialysis
IM 10.28
Describe and discuss the indications for renal replacement therapy
OBJECTIVES
1.Indication of renal replacement therapy
Describe discuss and communicate the ethical and legal issues involved in renal
IM 10.29
replacement therapy
OBJECTIVES
1.Communicating the ethical and legal issuses in RRT
IM 10.30
Recognise the impact of CKD on patient’s quality of life well being work and family
OBJECTIVES
1.Advice for quality of life and well being in CKD patients
IM 10.31
Incorporate patient preferences in to the care of CKD
OBJECTIVES
1.IncorporatIing patient preferences in CKD patients
143
CONSERVATIVE MANAGEMENT OF CHRONIC RENAL FAILURE
LECTURE/SGD
PHARMACOLOGY
144
DIALYSIS - RENAL REPLACEMENT THERAPY
SGD
145
CENTRAL VENOUS CATHETERISATIONA AND PERIPHERAL ACCESS IN DIALYSIS
DOAP
146
DIET AND COUSELLING FOR CHRONIC RENAL FAILURE
DOAP
147
RENAL TRANSPLANTATION
LECTURE
TOPIC
DIABETES MELLITUS
IM11.1
Define and classify diabetes
OBJECTIVES
1.Definition of Diabetes Mellitus
2.Classification of diabetes mellitus
Describe and discuss the epidemiology and pathogenesis and risk factors and
clinical evolution of type 1 diabetes
IM11.2
OBJECTIVES
1.Epidemiology of Type 1 Diabetes
2.Pathogenesis and risk factors
3.Clinical evolution
DIABETES MELLITUS - DEFINITION ,CLASSIFICATION AND TYPE 1 DM
148
LECTURE
PATHOLOGY
Describe and discuss the epidemiology and pathogenesis and risk factors
IM11.3
economic impact and clinical evolution of type 2 diabetes
OBJECTIVES
1.Epidemiology of Type 2 Diabetes
2.Pathogenesis and risk factors
3.Clinical evolution
Describe and discuss the genetic background and the influence of the environment
IM11.4
on diabetes
OBJECTIVES
1.Genetic basis in Diabetes
2.Influence of environment on diabetes
TYPE 2 DIABETES MELLITUS -EPIDEMIOLOGY,PATHOGENESIS AND
149
GENETIC BASIS
LECTURE
PATHOLOGY
TYPE 2 DIABETES MELLITUS -RISK FACTORS AND CLINICAL EVOLUTION
150
LECTURE
PATHOLOGY
Describe and discuss the pathogenesis and temporal evolution of microvascular
IM11.5
and macrovascular complications of diabetes
OBJECTIVES
1.Pathogenesis and evolution of microvascular complications in DM
2.Pathogenesis ans evolution of macrovascular complications in DM
MICRO AND MACRO VASCULAR COMPLICATIONS IN DIABETES MELLITUS
151
LECTURE
PATHOLOGY
Describe and discuss the pathogenesis and precipitating factors, recognition and
IM11.6
management of diabetic emergencies
OBJECTIVES
1.Enumerate the various diabetic emergencies
2.Pathogenesis of diabetic emergencies
3.Precipitating factors in Diabetic emergencies
4.Management of Diabetic emergencies
Describe and recognise the clinical features of patients who present with a diabetic
IM11.9
emergency
OBJECTIVES
1.Clinical features of Diabetic keto acidosis
2.Clinical features of HHS
Recognise the presentation of hypoglycaemia and outline the principles on its
IM11.14
therapy
OBJECTIVES
1.Definition of hypoglycemia
2.Presentation of hypoglycemia
3.Management of hypoglycemia
Recognise the presentation of diabetic emergencies and outline the principles of
IM11.15
therapy
OBJECTIVES
1.Presentation and management of Diabetic keto acidosis
2.Presentation and management of HHS
152
DIABETIC EMERGENCIES - AN OVERVIEW
LECTURE
Elicit document and present a medical history that will differentiate the aetiologies
of diabetes including risk factors, precipitating factors, lifestyle, nutritional history,
family history, medication history, co-morbidities and target organ disease
IM11.7
OBJECTIVES
1.Medical history in diabetes mellitus
2.Family history
3.Life style and nutritional history
Perform a systematic examination that establishes the diagnosis and severity that
includes skin, peripheral pulses, blood pressure measurement, fundus
examination, detailed examination of the foot (pulses, nervous and deformities and
IM11.8
injuries)
OBJECTIVES
1.Examination of skin in diabetes
2.Examination of vitals
3.Examination of fundus
4.Examination of foot
Generate a differential diagnosis and prioritise based on clinical features that
IM11.10
suggest a specific aetiology
OBJECTIVES
1.Differential diagnosis based on clinical features
HISTORY AND EXAMINATION IN DIABETES MELLITUS AND DIFFERENTIAL
153
DIAGNOSIS
SGD
Order and interpret laboratory tests to diagnose diabetes and its complications
including: glucoses, glucose tolerance test, glycosylated hemoglobin, urinary micro
albumin, ECG, electrolytes, ABG, ketones, renal function tests and lipid profile
IM11.11
OBJECTIVES
1.Glucose and GTT significance
2.HbA1C significance
3.Urinary microalbumin significance
4.ECG significance
5.RFT and electrolytes in Diabetes
6.ABG and lipid profile significance
IM11.12
Perform and interpret a capillary blood glucose test
OBJECTIVES
1.Observe and perform capillary blood glucose test
2.Interpretation of CBG
IM11.13
Perform and interpret a urinary ketone estimation with a dipstick
OBJECTIVES
1.Observe and perform urine dipstick test for ketones
2.Interpretatation of dipstick test
154
DIABETES MELLITUS - INVESTIGATIONS
LECTURE / SGD
BIOCHEMISTRY
Discuss and describe the pharmacologic therapies for diabetes their indications,
IM11.16
contraindications, adverse reactions and interactions
OBJECTIVES
1.Drug therapy- indications and contraindications in diabetes
2.Drug interactions
3.Drug adverse reaction
Outline a therapeutic approach to therapy of T2Diabetes based on presentation,
IM11.17
severity and complications in a cost effective manner
OBJECTIVES
1.Therapy based on presentation in diabetes
2.Therapy based on severity and complications in diabetes
Describe and discuss the pharmacology, indications, adverse reactions and
interactions of drugs used in the prevention and treatment of target organ damage
and complications of Type II Diabetes including neuropathy, nephropathy,
retinopathy, hypertension, dyslipidemia and cardiovascular disease
IM11.18
OBJECTIVES
1.Drug therapy in treatment of Target organ damage
2.Micro vascular and macrovascular complications in DM
155
DRUG THERAPY IN DIABETES MELLITUS
LECTURE
PHARMACOLOGY
Demonstrate and counsel patients on the correct technique to administer insulin
IM11.19
OBJECTIVES
1.Insulin therapy in diabetes
2.Observe correct technique to administer insulin
3.Perform and counsel correct technique to administer insulin
Demonstrate to and counsel patients on the correct technique of self monitoring of
IM11.20
blood glucoses
OBJECTIVES
1.Demonstrating the correct technique of self monitoring of CBG
2.Counselling
Recognise the importance of patient preference while selecting therapy for diabetes
IM11.21
OBJECTIVES
1.Selection of drug therapy for patients
156
INSULIN THERAPY AND COUNSELLING
LECTURE
PHARMACOLOGY
Enumerate the causes of hypoglycaemia and describe the counter hormone
IM11.22
response and the initial approach and treatment
OBJECTIVES
1.Causes of Hypoglycemia
2.Counter hormone response in hypoglycemia
3.Treatment of Hypoglycemia
157
HYPOGLYCEMIA - AN OVERVIEW
LECTURE
Describe the precipitating causes,pathophysiology, recognition, clinical features,
IM11.23
diagnosis, stabilisation and management of diabetic ketoacidosis
OBJECTIVES
1.Definition of DKA
2.Precipitating factors in DKA
3.Pathophysiology and clinical features in DKA
4.Diagnosis of DKA
5.Management of DKA
158
DIABETIC KETO-ACIDOSIS
LECTURE
Describe the precipitating causes, pathophysiology, recognition, clinical features,
diagnosis, stabilisation and management of Hyperosmolar non ketotic state
IM11.24
OBJECTIVES
1.Definition of HHS
2.Precipitating factors of HHS
3.Pathophysiology and clinical features in HHS
4.Diagnosis of HHS
5.Management of HHS
159
HYPEROSMOLAR HYPERGLYCEMIC NON KETOTIC STATE
LECTURE
TOPIC
THYROID DYSFUNCTION
Describe the epidemiology and pathogenesis of hypothyroidism and
hyperthyroidism including the influence of iodine deficiency and autoimmunity in
IM 12.1
the pathogenesis of thyroid disease
Objective
1. Pathogenesis of hypothyroidism
2. Normal iodine requirement of the body
3. Iodine autoimmunity in the pathogenesis of thyroid disease.
4. Role of iodine deficience in thyroid disease
IM 12.2
Describe and discuss the genetic basis of some forms of thyroid dysfunction
Objective
1.Genetic basis of thyroid disfunction
Describe and discuss the physiology of the hypothalamopituitary - thyroid axis,
principles of thyroid function testing and alterations in physiologic function
IM 12.3
Objective
1.Physiology of hypothalamopituitary - thyroid axis
2. Thyroid function and their importants
3. Functional Anatomy of thyroid gland
160
PHYSIOLOGY, EPIDEMIOLOGY, PATHOGENESIS OF THYROID DISORDER
LECTURE/SGD
PHYSIOLOGY
Describe and discuss the principles of radio iodine uptake in the diagnosis of
IM 12.4
thyroid disorders
Objective
1. Principles of Radio iodine uptake
Elicit document and present an appropriate history that will establish the diagnosis
IM 12.5
cause of thyroid dysfunction and its severity
Objective
1. History of thyroid disorder - palpitation, bradycardia
2. History of hypo thyroid
3. History of thyrotoxic disorder
Perform and demonstrate a systematic examination based on the history that will
help establish the diagnosis and severity including systemic signs of thyrotoxicosis
and hypothyroidism, palpation of the pulse for rate and rhythm abnormalities, neck
IM 12.6
palpation of the thyroid and lymph nodes and cardiovascular findings
Objective
1. General physical examination
2. Palpation of thyroid gland
3. Palpation of limb nodes
4. Importance of examination of cardio vascular system
IM 12.7
Demonstrate the correct technique to palpate the thyroid
Objective:
Technicque of palpation of thyroid gland
Generate a differential diagnosis based on the clinical presentation and prioritise it
IM 12.8
based on the most likely diagnosis
Objective:
Differential diagnosis based on clinical features
161
THYROID DISORDER - HISTORY ,EXAMINATION AND DIFFERENTIAL DIAGNOSIS
LECTURE/SGD
Order and interpret diagnostic testing based on the clinical diagnosis including
IM 12.9
CBC, thyroid function tests and ECG and radio iodine uptake and scan
Objective:
1. Blood examination : CBC, thyroid function test
2. ECG - interpretation
3. Interpretation of thyroid function test and blood analysis
4. Radio iodine uptake interpretation
5. Thyroid scan interpretation
IM 12.10
Identify atrial fibrillation, pericardial effusion and bradycardia on ECG
Objective:
1.ECG interpretation for arthymias
2.ECG interpretation of pericardial effusion.
3. Interpration of bradycardia and tachycardia
IM 12.11
Interpret thyroid function tests in hypo and hyperthyroidism
Objective:
1. Interpretation of thyroid function test
2. Interpretation of hyperthyroidism
3. Interpretation of hypothyroidism
162
THYROID DISORDER INVESTIGATIONS
LECTURE
IM 12.12
Describe and discuss the iodisation programs of the government of India
Objective:
1.National iodisation program
2. National goitore control program
163
NATIONAL IODISATION PROGRAM
SGD
COMMUNITY MEDICINE
Describe the pharmacology, indications, adverse reaction, interactions of thyroxine
IM 12.13
and antithyroid drugs
Objective:
1. Drug therapy of hypothyroidism
2. Interaction of thyroxine
3. Adverse reaction of antithyroid drugs
Write and communicate to the patient appropriately a prescription for thyroxine
IM 12.14
based on age, sex, and clinical and biochemical status
Objective:
1. Counselling the patient for the continuanity of thyroxine drugs
2. Communicate importance of thyroxine drugs
3. Observing follow of therapy based on clinical features
164
HYPOTHYROIDISM MANAGEMENT AND COUNSELLING
LECTURE/SGD
PHARMACOLOGY
Describe and discuss the indications of thionamide therapy, radio iodine therapy
IM 12.15
and surgery in the management of thyrotoxicosis
Objective:
1. Indications of thionamide therapy
2. Indications of radio iodine therapy
3. Medical management of thyrotoxicosis
4. Surgical management of thyrotoxicosis
5. Post operative care of thyroidectomy
165
MANAGEMENT OF HYPERTHYROIDISM AND THYROTOXICOSIS
LECTURE/SGD
PHARMACOLOGY
TOPIC
COMMON MALIGNANCIES
Describe the clinical epidemiology and inherited & modifiable risk factors for
IM 13.1
common malignancies in India
Objective:
1. Common malignancies in India
2. Clinical epidemiology of malignant disorders
3. Risk factors - modifiable and inheritable
IM 13.2
Describe the genetic basis of selected cancers
Objective:
1. Genetic basis of selective malignancies
IM 13.3
Describe the relationship between infection and cancers
Objective:
1. Difference between infection and malignancies
2. Symptoms and signs of infection
3. Creteria to rule out malignan disorders
166
COMMON MALIGNANCIES AND GENETIC FACTORS
LECTURE/SGD
PATHOLOGY
COMMON MALIGNANCIES - EPIDEMIOLOGY, RISKFACTORS AND DIFFERENCE BETWEEN
PATHOLOGY AND
167
INFECTION AND CANCER
LECTURE/SGD
MICOBIOLOGY
Describe the natural history, presentation, course, complications and cause of
IM 13.4
death for common cancers
Objective:
1.History of cancer
2.Common cancers
3 Presentation, course and complications
4. Cause of death
Describe the common issues encountered in patients at the end of life and
IM 13.5
principles of management
Objective:
1. Common issues of cancer patient
2. Principles of management
Describe and distinguish the difference between curative and palliative care in
IM 13.6
patients with cancer
Objective:
1. Curative therapy
2. Palliative therapy care
3. Difference between curative and palliative therapy
168
COMMON MALIGNANCIES -HISTORY ,CLINICAL PRESENTATION AND COMPLICATIONS
SGD
169
CURATIVE AND PALLIATIVE CARE IN CANCER THERAPY
LECTURE/SGD
PHARMACOLOGY
Elicit document and present a history that will help establish the aetiology of
IM 13.7
cancer and includes the appropriate risk factors, duration and evolution
Objective:
1. History to establish aetiology of malignan disorder
2. Risk factors of the cancer
3. Duration and evaluation of malignancy
Perform and demonstrate a physical examination that includes an appropriate
general and local examination that excludes the diagnosis, extent spread and
IM 13.8
complications of cancer
Objective:
1. General physical examination
2. Local examination for diagnosis
3. Assessment of extent of the disease
4. Complications of cancer
Demonstrate in a mannequin the correct technique for performing breast exam,
IM 13.9
rectal examination and cervical examination and pap smear
Objective:
1. Mannequin technique for breast examination
2. Technique of rectal examination
3. Technique for cervical examination
4. Pap smear technique
Generate a differential diagnosis based on the presenting symptoms and clinical
IM 13.10
features and prioritise based on the most likely diagnosis
Objective
1. Differential diagnosis based on symptom
2. Differential diagnosis bases on clinical features
3. Most likely diagnosis priority based symptoms and signs
170
SYMPTOM ANALYSIS AND CLINICAL DEMONSTRATION IN COMMON MALIGNANCIES
SGD
171
PHYSICAL EXAMINATION AND CLINICAL FEATURES OF COMMON MALIGNANCIES
SGD
Order and interpret diagnostic testing based on the clinical diagnosis including
IM 13.11
CBC and stool occult blood and prostate specific antigen
Objective:
1. Blood examination CBC and other specific test based on clinical features
2. Stool for occult blood
3. Prostate specific antigen Assessment
Describe the indications and interpret the results of Chest X Ray, mammogram,
IM 13.12
skin and tissue biopsies and tumor markers used in common cancers
Objective:
1. Indications for chest x-ray and interpretation
2. Mammogram and interpretation
3. Skin and tissue biopsies - histo pathological correlation
4. Tumor markers interpretation
172
INVESTIGATIONS OF COMMON MALIGNANCIES
LECTURE/SGD
IM 13.13
Describe and assess pain and suffering objectively in a patient with cancer
Objective:
1. Pain objective assessment
2. Plan for pain management
Describe the indications for surgery, radiation and chemotherapy for common
IM 13.14
malignancies
Objective:
1. Indications for chemotherapy
2. Indications for radiation
3. Indications for surgery
Describe the need, tests involved, their utility in the prevention of common
IM 13.15
malignancies
Objective:
1. Screening for common malignancies prevention
2. Test available for the prevention of malignancies
173
MANAGEMENT OF COMMON MALIGNANCIES - ASSESSMENT FOR TYPE OF TREATMENT
LECTURE
Demonstrate an understanding and needs and preferences of patients when
IM 13.16
choosing curative and palliative therapy
Objective:
1. Preference for chemotherapy
2. Preference for palliative therapy
Describe and enumerate the indications, use, side effects of narcotics in pain
IM 13.17
alleviation in patients with cancer
Objective:
1. Narcotic therapy in pain alleviation
2. Indications and uses of narcotic therapy
3. Side effect of narcotic therapy
IM 13.18
Describe and discuss the ethical and the medico legal issues involved in end of life care
Objective:
1. Ethical issues based on common malignancies management
2. Medico legal issues involved in norcatic therapy
3. Legal issues involved in end of life care
IM 13.19
Describe the therapies used in alleviating suffering in patients at the end of life
Objective:
1. Priorities of therapy at end of life
2. Indications for using modalities of treatment for alleviating suffering of the patient at
the end of life
PHARMACOLOGY ,
MANAGEMENT OF COMMON MALIGNANCIES PAIN AND ETHICAL ISSUES IN END OF LIFE
ANESTHISIOLOGY AND
PATIENT CARE
174
SGD
AETCOM
TOPIC
OBESITY
IM14.1
Define and measure obesity as it relates to the Indian population
OBESITY
1.Definition of obesity
2.Body mass index(BMI)
3.Various methods to measure BMI
4.Measurents in obesity
Describe and discuss the aetiology of obesity including modifiable and non-
IM14.2
modifiable risk factors and secondary causes
OBESITY
1.Etiology of obesity
2.Modifiable risk factors
3.Non-modifiable risk factors
4.Secondary causes of obesity
IM14.3
Describe and discuss the monogenic forms of obesity
OBJECTIVES
1.Monogenic forms of obesity
175
BODY MASS INDEX AND OBESITY - DEFINITION AND ETIOLOGY
LECTURE
Describe and discuss the impact of environmental factors including eating habits,
food, work, environment and physical activity on the incidence of obesity
IM14.4
OBJECTIVES
1.Influence of food habits
2.Environmental factors in obesity
3.Role of Physical activity
IM14.5
Describe and discuss the natural history of obesity and its complications
OBJECTIVES
1.Natural history of obesity
2.Complications of obesity
OBESITY - PATHOPHYSIOLOGY,NATURAL HISTORY AND COMPLICATIONS
176
LECTURE
PATHOLOGY
Elicit and document and present an appropriate history that includes the natural
history, dietary history, modifiable risk factors, family history, clues for secondary
IM14.6
causes and motivation to lose weight
OBJECTIVES
1.Natural history of obesity
2.Dietary history in obesity
3.Modifiable risk factors in obesity
4.Family history in obesity
5.Secondary causes of obesity
6. Motivating the patient to lose weight
Perform, document and demonstrate a physical examination based on the history
that includes general examination, measurement of abdominal obesity, signs of
IM14.7
secondary causes and comorbidities
OBJECTIVES
1.General Clinical examination in obesity
2.Anthropometric measurements
3.Measurement of abdominal obesity
4.Signs in obesity
5.Comorbidities in obesity
Generate a differential diagnosis based on the presenting symptoms and clinical
IM14.8
features and prioritise based on the most likely diagnosis
OBJECTIVES
1.Differential diagnosis based on symptoms
2.Differential diagnosis based on clinical features
OBESITY -HISTORY,CLINICAL EXAMINATION AND DIFFERENTIAL
177
DIAGNOSIS
SGD
Order and interpret diagnostic tests based on the clinical diagnosis including blood
IM14.9
glucose, lipids, thyroid function tests etc.
OBJECTIVES
1.Blood glucose level in obesity
2.Fasting lipid profile in obesity
3.Throid function tests in obesity
4.Hormonal assays in obesity
178
INVESTIGATIONS IN OBESITY
SGD
Communicate and counsel patient on behavioural, dietary and lifestyle
IM14.11
modifications
OBJECTIVES
1.Dietary advice counselling
2.Lifestyle modifications counselling
3.Significance of physical activity
Demonstrate an understanding of patient’s inability to adhere to lifestyle
IM14.12
instructions and counsel them in a non - judgemental way
OBJECTIVES
1.Empathising with patients lifestyle difficulties
2.Counselling the patients on adhering to healthy lifestyle
Describe and enumerate the indications, pharmacology and side effects of
IM14.13
pharmacotherapy for obesity
OBJECTIVES
1.Indications of drugs in obesity
2.Pharmacology of drugs in obesity
3.Adverse effect of drug therapy
OBESITY- PHARMACOLOGICAL MANAGEMENT AND LIFE STYLE
179
MODIFICATIONS
LECTURE
PHARMACOLOGY
IM14.14
Describe and enumerate the indications and side effects of bariatric surgery
OBJECTIVES
1.Types of bariatric surgery
2.Indications of bariatric surgery
3.Contraindications of bariatric surgery
Describe and enumerate and educate patients, health care workers and the public
IM14.15
on measures to prevent obesity and promote a healthy lifestyle
OBJECTIVES
1.Various health measures for prevention of obesity
2.Creating awareness about obesity among health care workers
3.Educating the public about adverse outcomes of obesity
5.Counselling the public to promote healthy life style
180
OBESITY - SURGICAL MANAGEMENT AND COUNSELLING PREVENTIVE MEASURES
LECTURE/SGD
GENERAL SURGERY
TOPIC
GI bleeding
IM 15.1
Enumerate, describe and discuss the aetiology of upper and lower GI bleeding
OBJECTIVES
1.Common causes for Upper GI bleed
2.Causes for Lower GI Bleed
3.Factors that precipitate GI bleed
Enumerate, describe and discuss the evaluation and steps involved in stabilizing a patient
IM 15.2
who presents with acute volume loss and GI bleed
OBJECTIVES
1.Moniter the vitals to assess the volume loss
2.Identify site and source of blood loss
3.Stabilizing the patient by volume replacements - colloids or crystalloids
IM 15.3
Describe and discuss the physiologic effects of acute blood and volume loss
OBJECTIVES
1.Physiological changes that takes place due to acute blood loss
2.The effects of acute blood loss changes identified
PATHOLOGY AND
181
UPPER AND LOWER GI BLEED- ETIOLOGY,RISK FACTORS AND PATHOGENESIS
LECTURE/SGD
GENERAL SURGERY
182
UPPER AND LOWER GI BLEED-ASSESSMENT AND STABILIZATION
LECTURE/SGD
GENERAL SURGERY
Elicit and document and present an appropriate history that identifies the route of
bleeding, quantity, grade, volume loss, duration, etiology, comorbid illnesses and risk
IM 15.4
factors
OBJECTIVES
1.History of route of bleeding
2.Quantity and grade of volume loss
3.Duration and cause of blood loss
4.Risk factors and co-morbid illness
Perform, demonstrate and document a physical examination based on the history that
IM 15.5
includes general examination, volume assessment and appropriate abdominal examination
OBJECTIVES
1.General examination-assesing the signs of blood loss-Pulse volume/BP
2.Abdominal examination-Identify source of bleed
Distinguish between upper and lower
gastrointestinal bleeding based on the clinical features
IM 15.6
OBJECTIVES
1.Difference between Upper GI bleed and Lower GI bleed
2.Clinical examination of the upper abdomen
3.Per-Rectal examination to assess lower GI bleed
Demonstrate the correct technique to perform an anal and rectal examination in a
IM 15.7
mannequin or equivalent
OBJECTIVES
1.Technique to perform rectal examination
2.Indications and Contra-indication of rectal examination
3.Interpretation of rectal examination
Generate a differential diagnosis based on the presenting symptoms and clinical features
IM 15.8
and prioritise based on the most likely diagnosis
OBJECTIVES
1.Differential diagnosis based on symptoms and signs
2.Priority of diagnosis based on clinical feature
183
GI BLEED CLINICAL FEATURE AND DIFFERENTIAL DIAGNOSIS
LECTURE/SGD
Choose and interpret diagnostic tests based on the clinical diagnosis including complete
IM 15.9
blood count, PT and PTT, stool examination, occult blood, liver function tests, H.pylori test.
OBJECTIVES
1.Blood investigations-Hb,CBC,PCV,Blood grouping
2.PTT/PT, INR
3.Stool examination for occult blood,Liver function test,H.Pylori test
Enumerate the indications for endoscopy, colonoscopy and other imaging procedures in
IM 15.10
the investigation of Upper GI bleeding
OBJECTIVES
1.Indications and Contra-Indications for upper GI scopy
2.Indications and Contra-indication for colonoscopy
3.USG abdomen
184
GI BLEED- INVESTIGATIONS
LECTURE/SGD
Develop, document and present a treatment plan that includes fluid resuscitation, blood
IM 15.11
and blood component transfusion, and specific therapy for arresting blood loss
OBJECTIVES
1.Treatment plan for fluid resursitation by assessing volume loss
2.Plan for blood ,blood components transfusion
3.Protocols for blood transfusion and tranfusion related precautions
4.Specific therapy for arresting blood loss
Enumerate the indications for whole blood, component and platelet transfusion and
IM 15.12
describe the clinical features and management of a mismatched transfusion
OBJECTIVES
1.Indications for blood and blood components tranfusion
2.Protocols for blood transfusion and tranfusion related precautions
3.Monitering the clinical features of mismatched transfusion
IM 15.13
Observe cross matching and blood / blood component transfusion
OBJECTIVES
1.Blood and blood components tranfusion- Cross matching procedures
2.Blood collection from the blood bank procedures
3.Pre-tranfusion and Post-tranfusion precautionary measures
185
MANAGEMENT OF GI BLEED
LECTURE/SGD
GENERAL SURGERY
Describe and enumerate the indications, pharmacology and side effects of
IM 15.14
pharmacotherapy of pressors used in the treatment of Upper GI bleed
OBJECTIVES
1.Indications of drug therapy
2.Side effects of drug therapy
Describe and enumerate the indications, pharmacology and side effects of
IM 15.15
pharmacotherapy of acid peptic disease including Helicobacter pylori
OBJECTIVES
1.Indications of drug therapy in acid peptic disease
2.Drugs used and side effects
3.Drug combination used in Helicobacter Pylori
IM 15.16
Enumerate the indications for endoscopic interventions and Surgery
OBJECTIVES
1.Indications for endoscopic intervention
2.Preperation of patient for endoscopy and interpretation of endoscopic results
3.Indication for surgical procedure in GI Bleed
IM 15.17
Determine appropriate level of specialist consultation
OBJECTIVES
1.Assessing the patient's volume loss
2.Intervention for correcting the volume loss
3.For special procedures to arrest the GI bleed
Counsel the family and patient in an empathetic non-judgmental manner on the diagnosis
IM 15.18
and therapeutic options
OBJECTIVES
1.Councelling the family members
2.councellimg the patient for diagnostic and therapeutic options
PHARMACOLOGY AND
186
MANAGEMENT OF PEPTIC ULCER ,H.PYLORI AND COUNCELLING
LECTURE/SGD
MICROBIOLOGY
TOPIC
Diarrheal disorder
Describe and discuss the aetiology of acute and chronic diarrhea including infectious and
IM 16.1
non infectious causes
OBJECTIVES
1.Etiology of acute and chronic diarrheoa
2.Etiology of infectious and non-infectious diarrheoa
Describe and discuss the acute systemic consequences of diarrhea including its impact on
IM 16.2
fluid balance
OBJECTIVES
1.Systemic consequences of acute diarrheoa
2.Consequences of fluid loss
IM 16.3
Describe and discuss the chronic effects of diarrhea including malabsorption
OBJECTIVES
1.Effects of chronic diarrheoa
2.Causes of malabsorption
187
ACUTE AND CHRONIC DIARRHEOA-ETIOLOGY AND EFFECTS OF FLUID LOSS
LECTURE/SGD
MICROBIOLOGY
Elicit and document and present an appropriate history that includes the natural history,
IM 16.4
dietary history, travel , sexual history and other concomitant illnesses
OBJECTIVES
1.Various history for diarrheoa
2.Associated concomitant disease
Perform, document and demonstrate a physical examination based on the history that
IM 16.5
includes general examination, including an appropriate abdominal examination
OBJECTIVES
1.General physical examination to assess the hydration status
2.Abdominal examination and clinical features of diarrheoa
IM 16.6
Distinguish between diarrheoa and dysentery based on clinical features
OBJECTIVES
1.Difference between diarrheoa and dysentry
2.Clinical features of diarrheoa and dysentry
Generate a differential diagnosis based on the presenting symptoms and clinical features
IM 16.7
and prioritise based on the most likely diagnosis
OBJECTIVES
1.Differential diagnosis diarrheoa and dysentry
188
DIARRHEAL DISEASES -CLINICAL PRESENTATION AND DIFFERENTIAL DIAGNOSIS
SGD
Choose and interpret diagnostic tests based on the clinical diagnosis including complete
IM 16.8
blood count, and stool examination
OBJECTIVES
1.Complete blood examination
2.Stool examination-ova cyst
IM 16.9
Identify common parasitic causes of diarrhea under the microscope in a stool specimen
OBJECTIVES
1.Microscopic stool examination- procedures and interpretation
IM 16.10
Identify vibrio cholera in a hanging drop specimen
OBJECTIVES
1.Method of hanging drop preparation
2.Interpretation of hanging drop specimen
Enumerate the indications for stool cultures and blood cultures in patients with acute
IM 16.11
diarrhea
OBJECTIVES
1.Stool culture- how and when to do it
2.Blood culture for enteric and non-enteric bacilli
Enumerate and discuss the indications for further investigations including antibodies,
IM 16.12
colonoscopy, diagnostic imaging and biopsy in the diagnosis of chronic diarrhea
OBJECTIVES
1.Indications for special investigations for chronic diarrhea
189
INVESTIGATIONS OF DIARRHOEAL DISEASES
SGD
MICROBIOLOGY
Describe and enumerate the indications, pharmacology and side effects of
IM 16.13
pharmacotherapy for parasitic causes of diarrhea
OBJECTIVES
1.Drug therapy of parasite causing diarrhea
2.Side effects of drug therapy
Describe and enumerate the indications, pharmacology and side effects of
IM 16.14
pharmacotherapy for bacterial and viral diarrhea
OBJECTIVES
1.Drug therapy of bacteria and virus causing diarrhea
2.Side effects of drug therapy
190
MANAGEMENT OF DIARRHEAL DISEASES
LECTURE/SGD
PHARMACOLOGY
IM 16.15
Distinguish based on the clinical presentation Crohn’s disease from Ulcerative Colitis
OBJECTIVES
1.Clinical features of Crohn's disease
2.Clinical features of Ulcerative Colitis
3.Difference between Crohn's disease and Ulcerative Colitis
Describe and enumerate the indications, pharmacology and side effects of
IM 16.16
pharmacotherapy including immunotherapy
OBJECTIVES
1.Drug therapy of Inflamatory bowel disease
2.Side effects of drug therapy
3.Indications and side effects of immunotherapy
IM 16.17
Describe and enumerate the indications for surgery in inflammatory bowel disease
OBJECTIVES
1.Indications for surgery in inflammatory bowel disease
191
ULCERATIVE COLITIS -PATHOPHYSIOLOGY ,CLINICAL FEATURES AND MANAGEMENT
LECTURE
PATHOLOGY
192
CROHN'S DISEASE - PATHOPHYSIOLOGY, CLINICAL FEATURES AND MANAGEMENT
LECTURE
PATHOLOGY
TOPIC
HEADACHE
Define and classify headache and describe the presenting features, precipitating
factors, aggravating and relieving factors of various kinds of headache
IM17.1
OBJECTIVES
1.Definition of Headache
2.Classification of headache
3.Clinical features of various forms of heaadche
4.Precipitating factors in headache
5.Aggrevating and relieving factors in different types of headache
6. Define meningitis and various types of meningitis
HEADACHE - DEFINITION ,CLASSIFICATION OF HEADACHE AND
193
MENINGITIS
LECTURE/SGD
Elicit and document and present an appropriate history including aura, precipitating
aggravating and relieving factors, associated symptoms that help identify the
IM17.2
cause of headaches
OBJECTIVES
1.Definition of aura
2.History of headache -onset,duration
3.History of headache - aggrevating factors and relieving factors
4.History of headche with associated symptoms like photophobia
Classify migraine and describe the distinguishing features between classical and
IM17.3
non classical forms of migraine
OBJECTIVES
1.Definition of migraine
2.Classification of migraine
3.Difference between Classical and non classical migraine
194
HEADACHE - MIGRAINE
LECTURE/SGD
Perform and demonstrate a general neurologic examination and a focused
examination for signs of intracranial tension including neck signs of meningitis
IM17.4
OBJECTIVES
1. Signs of intracranial tension
2. Neck signs in meningitis
3. General neurological examination
4. Demonstration of neck signs in meningitis
Generate document and present a differential diagnosis based on the clinical
IM17.5
features, and prioritise the diagnosis based on the presentation
OBJECTIVES
1. Pathophysiology of meningitis
2.Differential diagnosis of headache
MENINGITIS -PATHOPHYSIOLOGY ,CLNICAL FEATURES AND DIFFRENTIAL
MICROBIOLOGY AND
195
DIAGNOSIS
LECTURE
PATHOLOGY
Choose and interpret diagnostic testing based on the clinical diagnosis including
IM17.6
imaging
OBJECTIVES
1.Diagnostic testing in headaches like imaging
2.Interpretation of imaging
Enumerate the indications and describe the findings in the CSF in patients with
IM17.7
meningitis
OBJECTIVES
1.Indications and contraindications of Lumbar puncture
2.Observe Lumbar puncture procedure
3. Interpretation of CSF analysis in meningitis
Demonstrate in a mannequin or equivalent the correct technique for performing a
IM17.8
lumbar puncture
OBJECTIVES
1.Observe lumbar puncture
2.Demonstrate correct technique of lumbar puncture
Interpret the CSF findings when presented with various parameters of CSF fluid
IM17.9
analysis
OBJECTIVES
1.CSF analysis
2.Interpretation of glucose in CSF analysis
3.Interpretation of protein in CSF analysis
4.Interpretation of cell count in CSF analysis
INVESTIGATIONS IN HEADACHE AND MENINGITIS
MICROBIOLGY AND
196
LECTURE/SGD
PATHOLOGY
Enumerate the indications for emergency care admission and immediate
IM17.10
supportive care in patients with headache
OBJECTIVES
1.Emergencies in headache
2.Admission criteria of headache in emergency care
3.Management of headache in emergency care
197
ACUTE EMERGENCIES IN HEADACHE AND MANAGEMENT
LECTURE/SGD
Describe the indications, pharmacology, dose, side effects of abortive therapy in
IM17.11
migraine
OBJECTIVES
1.Indications of therapy in migraine
2.Drug therapy and its side effects in megraine
3.Abortive therapy in migraine
4.Adverse effects of abortive therapy
Describe the indications, pharmacology, dose, side effects of prophylactic therapy
IM17.12
in migraine
OBJECTIVES
1.Indications of prophylaxis in migraine
2.Drug prophylaxis in migraine
3.Adverse effects of drug prophylaxis
198
MIGRAINE - MANAGEMENT AND PROPHYLAXIS
LECTURE/SGD
PHARMACOLOGY
Describe the pharmacology, dose, adverse reactions and regimens of drugs used
IM17.13
in the treatment of bacterial, tubercular and viral meningitis
OBJECTIVES
1.Drug therapy in bacterial meningitis and its adverse effects
2.Drug therapy in TB meningitis and its adverse effects
3.Drug therapy in Viral meningitis and its adverse effects
199
MENINGITIS - MANAGEMENT
LECTURE/SGD
PHARMACOLOGY
Counsel patients with migraine and tension headache on lifestyle changes and
IM17.14
need for prophylactic therapy
OBJECTIVES
1.Life style modification counselling for patients with migraine
2.Counselling for prophylaxis for migraine
200
COUNSELLING FOR PROPHYLACTIC THERAPY IN MIGRAINE
DOAP
TOPIC
CEREBROVASCULAR ACCIDENT
IM18.1
Describe the functional and the vascular anatomy of the brain
OBJECTIVES
1.Functional anatomy of brain
2.Blood supply of brain
3.Physiology of brain
4.Applied aspects in blood supply of brain
BRAIN -FUNCTIONAL ANATOMY,PHYSIOLOGY ,BLOOD SUPPLY AND
ANATOMY AND
201
APPLIED ASPECTS
LECTURE
PHYSIOLOGY
Classify cerebrovascular accidents and describe the aetiology, predisposing
genetic and risk factors pathogenesis of hemorrhagic and non hemorrhagic stroke
IM18.2
OBJECTIVES
1.Define CVA
2.Classification of CVA
3.Etiology of CVA
4.Genetic factors and risk factors in CVA
5.Pathogenesis of hemmorhagic stroke
6.Pathogenesis of ischemic and embolic stroke
7.Clionical presentation of ischemic and embolic stroke
8.Clinical presentation of hemorrhagic stroke
202
CVA - DEFINITION ,CLASSIFICATION AND ETIOPATHOGENESIS
LECTURE
CVA- CLINICAL FEATURES OF ISCHEMIC AND EMBOLIC STROKE
203
LECTURE
CVA - CLINICAL FEATURES OF HEMMORHAGIC STROKE
204
LECTURE
Elicit and document and present an appropriate history including onset,
progression, precipitating and aggravating relieving factors, associated symptoms
IM18.3
that help identify the cause of the cerebrovascular accident
OBJECTIVES
1.History taking in CVA
2.History - onset , duration and progression of stroke
3.History - Precipitating,aggrevating and relieving factors in stroke
4.History of associated symptoms in stroke
205
HISTORY AND SYMPTOM ANALYSIS IN STROKE
SGD
Identify the nature of the cerebrovascular accident based on the temporal evolution
IM18.4
and resolution of the illness
OBJECTIVES
1.Diagnosis based on history and evolution of stroke
Perform, demonstrate & document physical examination that includes general and
a detailed neurologic examination as appropriate, based on the history
IM18.5
OBJECTIVES
1.Observe general examination and neurological examination
2.Demonstrate neurological examination based on history
206
GENERAL AND NEUROLOGICAL EXAMINATION IN STROKE
SGD
Distinguish the lesion based on upper vs lower motor neuron, side, site and most
IM18.6
probable nature of the lesion
OBJECTIVES
1.Upper motor neuron and lower motor neuron - Anatomy
2.Difference between upper motor neuron and lower motor neuron
3.Identifying the type of leison
4.Localising the site of leison
UPPER MOTOR NEURON, LOWER MOTOR NEURON AND LOCALISATION
207
OF LEISON
SGD
Describe the clinical features and distinguish, based on clinical examination, the
IM18.7
various disorders of speech
OBJECTIVES
1.Anatomy and Physiology of speech
2.Discuss the various disorders of speech like aphasia and dysphasia
3.Difference between motor aphasia and sensory aphasia
4.Clinical examination to differentiate disorders of speech
208
SPEECH AND DISORDERS OF SPEECH - AN OVERVIEW
SGD
Describe and distinguish, based on the clinical presentation, the types of bladder
IM18.8
dysfunction seen in CNS disease
OBJECTIVES
1.Anatomy and Physiology of bladder
2.Different types of bladder leisons
3.Clinical presentation of neurogenic bladder
4.Clinical presentation of atonic bladder
BLADDER - ANATOMY ,PHYSIOLOGY AND DYSFUNCTION IN CNS DISEASES
209
LECTURE/SGD
Choose and interpret the appropriate diagnostic and imaging test that will delineate
IM18.9
the anatomy and underlying cause of the lesion
OBJECTIVES
1.Blood and CSF analysis in brain leisons
2.Imaging like CT brain and MRI in brain leisons
3.Interpretations of the investigations
210
INVESTIGATIONS IN STROKE
LECTURE/SGD
RADIOLOGY
Choose and interpret the appropriate diagnostic testing in young patients with a
IM18.10
cerebrovascular accident (CVA)
OBJECTIVES
1.Definition of young stroke
2.Etiology of Young stroke
3.Role of protein -C and protein -S in young stroke
4.Pathophysiology of young stroke
5.Clinical features in young stroke
6.Blood investigations in young stroke
7.Imaging in Young stroke
8.Interpretation of Imaging in Young stroke
211
YOUNG STROKE
LECTURE
Describe the initial supportive management of a patient presenting with a
IM18.11
cerebrovascular accident (CVA)
OBJECTIVES
1.Treatment modalities available for acute stroke
2.Acute stroke protocol
3.Supportive measures in management of acute stroke
Enumerate the indications for and describe acute therapy of non hemorrhagic
IM18.12
stroke including the use of thrombolytic agents
OBJECTIVES
1.Thromolysis in acute non-hemoorhagic stroke
2.Indications and contraindications of thrombolysis
3.Adverse effects of thrombolysis
$.Clinical outcome of thrombolysis.
Enumerate the indications for and describe the role of anti platelet agents in non
IM18.13
hemorrhagic stroke
OBJECTIVES
1.Pharamacological agents used in Non- hemmorhagic stroke
2.Role of antiplatelets in Non- hemmorhagic stroke
3.Indications and contraindications of antiplatelets in stroke
3.Role of statins in Non- hemmorhagic stroke
212
NON-HEMMORHAGIC STROKE MANAGEMENT
LECTURE/SGD
IM18.14
Describe the initial management of a hemorrhagic stroke
OBJECTIVES
1.Hemorrhagic stroke and its various presentations
2.Role of mannitol in hemmorhagic stroke
3.Drug therapy in management of hemmorhagic stroke
IM18.15
Enumerate the indications for surgery in a hemorrhagic stroke
OBJECTIVES
1.Surgical procedures in hemorrhagic stroke
2.Indications for surgery in hemorrhagic stroke
3.Contraindications of surgery in hemoorhagic stroke
213
HEMORRHAGIC STROKE - MANAGEMENT
LECTURE/SGD
Enumerate the indications describe and observe the multidisciplinary rehabilitation
IM18.16
of patients with a CVA
OBJECTIVES
1.Role of rehabilitation in stroke patients
2.Various methods of rehabilitation
3.Indications for rehabilitation in CVA patients
Counsel patient and family about the diagnosis and therapy in an empathetic
IM18.17
manner
OBJECTIVES
1.Empathising with patient and his/her family
2.Counsel the patient regarding daignosis
3.Counselling the patient on therapy
214
STROKE REHABILITATION AND COUNSELLING
SGD
TOPIC
Movement disorders
IM 19.1
Describe the functional anatomy of the locomotor system of the brain
OBJECTIVES
1.Anatomy of locomotor system
2.Components of Musculoskeletal system
Classify movement disorders of the brain based on distribution, rhythm, repetition,
IM 19.2
exacerbating and relieving factors
OBJECTIVES
1.Classification of movement disorders
2.Exacerbating and relieving factors
Elicit and document and present an appropriate history including onset, progression
precipitating and aggravating relieving factors, associated symptoms that help identify the
IM 19.3
cause of the movement disorders
OBJECTIVES
1.Elicitation of history of movement disorders
2.Aggrevating and relieving factors of movement disorders
3.History that helps to identify the etiology of movement disorder
MOVEMENT DISORDERS-FUNCTIONAL ANATOMY,CLASSIFICATION AGGREVATING
ANATOMY AND
215
RELIEVING FACTORS
LECTURE/SGD
PHYSIOLOGY
Perform, demonstrate and document a physical examination that includes a general
IM 19.4
examination and a detailed neurologic examination using standard movement rating scales
OBJECTIVES
1.General physical examination
2.Detailed neurological examination examination
3.Standard movement disorder rating scales
Generate document and present a differential diagnosis and prioritise based on the
IM 19.5
history and physical examination
OBJECTIVES
1.Based on physical examination and history types of movement disorder
2.Documentation of movement disorder
3.Differential diagnosis based on demonstration of movement disorders
Make a clinical diagnosis regarding on the anatomical location, nature and cause of the
IM 19.6
lesion based on the clinical presentation and findings
OBJECTIVES
1.Clinicsl features based diagnosis
2.Clinical features based , Anatomical site of lesion
3.Nature of the lesion and etiology
216
MOVEMENT DISORDERS CLINICAL FEATURES AND DEMONSTRATION
DOAP
IM 19.7
Choose and interpret diagnostic and imaging tests in the diagnosis of movement disorders
OBJECTIVES
1.Imaging interpretation- MRI, CT Brain
Discuss and describe the pharmacology, dose, side effects and interactions used in the
IM 19.8
drug therapy of Parkinson’s syndrome
OBJECTIVES
1.Drug therapy in Parkinson's disorder
2.Side effect,drug interaction of anti-parkinson drugs
3.Other drugs like benzodiazpines, tranquilizers uses in movement disorders
Enumerate the indications for use of surgery and botulinum toxin in the treatment of
IM 19.9
movement disorders
OBJECTIVES
1.Indications for surgical therapy-stereotactic destruction
2.Botulinum toxin in treatment of movement disorder
217
CHOREA - CLASSFICATION AND CLINICAL FEATURES
LECTURE
218
PARKINSON'S DISEASE AND MANAGEMENT
LECTURE
PHARMOCOLOGY
219
INVESTIGATION AND MANAGEMENT OF MOVEMENT DISORDERS
SGD
RADIOLOGY
TOPIC
Envenomation
Enumerate the local poisonous snakes
and describe the distinguishing marks of each
IM 20.1
OBJECTIVES
1.Various types of poisonous snakes
2.Distinguish poisonous snake from non-poisonous snakes
3.Difference between various types of poisonuous snakes
Describe, demonstrate in a volunteer or a mannequin and educate (to other health care
IM 20.2
workers / patients) the correct initial management of patient with a snake bite in the field
OBJECTIVES
1.Educating the initial management of snake envenomation patient
2.Educating Do's and Don'ts in initial managements
3.Educate to identify the poisonous snakes
Describe the initial approach to the stabilisation of the patient who presents with snake
IM 20.3
bite
OBJECTIVES
1.Monitering the vital signs
2.Identifing the type of snake envenomation
3.Assessing the nature of toxins-cardiotoxic/neurotoxic
4.Identifying the systemic envenomation
5.Stabilizing the patient with ASV and parenteral IV fluids
Elicit and document and present an appropriate history, the circumstance, time, kind of
IM 20.4
snake, evolution of symptoms in a patient with snake bite
OBJECTIVES
1.History regarding kind of snake , time and circumstances
2.Assessing the symptoms related system envenomation
Perform a systematic examination, document and present a physical examination that
includes general examination, local examination, appropriate cardiac and neurologic
IM 20.5
examination
OBJECTIVES
1.General physical examination
2.Local examination at the site of bite
3.Examination of neurological and cardiovascular system to assess systemic
envenomation
220
SNAKE ENVENOMATION AND CLINICAL ASSESSMENT
LECTURE/SGD
FORENSIC MEDICINE
IM 20.6
Choose and interpret the appropriate diagnostic testing in patients with snake bites
OBJECTIVES
1.Blood investigations-Bleeding time,clotting time,PT
2.ECG for cardiotoxic
Enumerate the indications and describe the pharmacology, dose, adverse reactions,
IM 20.7
hypersensitivity reactions of anti snake venom
OBJECTIVES
1.Indications for ASV
2.Test dose of ASV to assess hypersensitivity
3.Dose of ASV
4.Adverse reaction of ASV
221
SNAKE ENVENOMATION MANAGEMENT
LECTURE/SGD
PHARMOCOLOGY
Describe the diagnosis, initial approach stabilisation and therapy of scorpion
IM 20.8
envenomation
OBJECTIVES
1.History of scorpion sting
2.Assessment of local toxic effect
3.Assessment of systemic toxin
4.Stabilization by IV fluids,antihistamine,cocktail therapy
IM 20.9
Describe the diagnosis initial approach stabilisation and therapy of bee sting allergy
OBJECTIVES
1.History of bee sting
2.Assessment of local and systemic toxic effect
3.Initial approach by monitering the vitals and pain managment
4.Stabilization by antihistamine and other drug therapy
222
MANAGEMENT OF SCORPION STING AND BEE STING
LECTURE/SGD
TOPIC
Poisoning
Describe the initial approach to the
stabilisation of the patient who presents with poisoning
IM 21.1
OBJECTIVES
1.History to identify the nature and type of poison
2.Registering AR entry
3.Initiation of stomach wash
4.Stabilizing the patient with universal antidote after assessing the vitals
223
POISONING- GENERAL APPROACH
LECTURE/SGD
Enumerate the common plant poisons seen in your area and describe their toxicology,
IM 21.2
clinical features, prognosis and specific approach to detoxification
OBJECTIVES
1.Common plant poisons
2.Toxic effects of the particular poisons
3.Clinical manifestations of plant poisons
4.Universal antidote and specific detoxification drugs
5.Organophosphorous compunds poisoning - Etiopathogenesis ,clinical features
224
PLANT POISONS AND MANAGEMENTS
LECTURE/SGD
225
ORGANOPHOSPHOROUS POISONING AND ITS MANAGEMENT
LECTURE/SGD
PHARMOCOLOGY
Enumerate the common corrosives used in your area and describe their toxicology, clinical
IM 21.3
features, prognosis and approach to therapy
OBJECTIVES
1.Common corrosive poisons
2.Toxic effects of each poison
3.Clinical presentation of each poison
4.Indication and contraindications for stomach wash
5.Stablisation approach and specific antidote therapy
6.Common non corrosive poisons
7.Clinical presentation of non-corosive poisons
8.Management of non-corrosive poisons
226
CORROSIVE POISONS AND MANAGEMENT
LECTURE/SGD
227
NON CORROSIVE POISONING AND ITS MANAGEMENT
LECTURE/SGD
Enumerate the commonly observed drug overdose in your area and describe their
IM 21.4
toxicology, clinical features, prognosis and approach to therapy
OBJECTIVES
1.History to identify overdose drug
2.Identify the normal therapeutic dose of the drug
3.Identify the toxic dose of the drug
4.Clinical presentation of the overdose of the drug
5.Stabilising the general condition and specific antidote of the drug
228
DRUGS OVERDOSE AND MANAGEMENT
LECTURE
PHARMOCOLOGY
IM 21.5
Observe and describe the functions and role of a poison center in suspected poisoning
OBJECTIVES
1.Locating the nearby poison centre
2.National poison centre functions
3.Collecting the information regarding Antidote of specific poison
4.Functions of Institutional pharmacovigliance committee
229
POISON CENTRES /PHARMACOVIGILANCE COMMITTEE
SGD
FORENSIC MEDICINE
Describe the medico legal aspects of suspected suicidal or homicidal poisoning and
demonstrate the correct procedure to write a medico legal report on a suspected
IM 21.6
poisoning
OBJECTIVES
1.Medicolegal registration at casuality
2.Intimation of poison and copy of medicolegal registration to police station
3.Monitoring the vitals
4.Collecting the detailed information regarding the poison consumption
Counsel family members of a patient with suspected poisoning about the clinical and
IM 21.7
medico legal aspects with empathy
OBJECTIVES
1.Councelling the family members of the patient regarding the nature of the poison
2.Exaplain the clinical nature and medicolegal aspect
MEDICOLEGAL REGISTRATION OF POISONING AND COUNsELLING THE FAMILY MEMBERS
230
SGD
FORENSIC MEDICINE
Enumerate the indications for psychiatric consultation and describe the precautions to be
IM 21.8
taken in a patient with suspected suicidal ideation / gesture
OBJECTIVES
1.Indications for psychiatric consultation
2.Precaution ot moniter suicidal attempted patients
231
PSYCHIATRIC COUNSELLING - SUICIDAL ATTEMPTED PATIENTS
DOAP
PSYCHIATRY
TOPIC
MINERAL ,FLUID ELECTROLYTE AND ACID BASE DISORDER
Enumerate the causes of hypercalcemia and distinguish the features of PTH vs
IM22.1
non PTH mediated hypercalcemia
OBJECTIVES
1.Calcium metabolisim and role of PTH
2.Causes of hpercalcemia
Describe the aetiology, clinical manifestations, diagnosis and clinical approach to
IM22.2
primary hyperparathyroidism
OBJECTIVES
1.Definition of primary hyperparathyroidism
2.Etiology of primary hyperparathyroidism
3.Clinical manifestations of primary hyperparathyroidism
4.Diagnosis of primary hyperparathyroidism
5.Clinical approach in primary hyperparathyroidism
IM22.3
Describe the approach to the management of hypercalcemia
OBJECTIVES
1.Clinical manifestations of hpercalcemia
2.Approach to management of hypercalcemia
CALCIUM METABOLISM, HYPERCALCEMIA,CLINICAL PRESENTATION AND
232
MANAGEMENT
LECTURE
233
HYPERPARATHYROIDISM
LECTURE
GENERAL SURGERY
Enumerate the components and describe the genetic basis of the multiple
IM22.4
endocrine neoplasia syndrome
OBJECTIVES
1.Definition of MEN
2.Components of MEN syndrome
3.Genetic basis of MEN
234
MULTIPLE ENDOCRINE NEOPLASIA
LECTURE
PATHOLOGY
Enumerate the causes and describe the clinical features and the correct approach
to the diagnosis and management of the patient with hyponatremia
IM22.5
OBJECTIVES
1.Definition of Hyponatremia
2.Causes of hyponatremia
3.Clinical features in Hyponatremia
4.Diagnosis of hyponatremia
5.Management of hyponatremia
235
HYPONATREMIA
LECTURE
Enumerate the causes and describe the clinical and laboratory features and the
correct approach to the diagnosis and management of the patient with
IM22.6
hypernatremia
OBJECTIVES
1.Definition of Hypernatremia
2.Causes of hypernatremia
3.Clinical features in Hypernatremia
4.Diagnosis of hypernatremia
5.Management of hypernatremia
236
HYPERNATREMIA
LECTURE
Enumerate the causes and describe the clinical and laboratory features and the
correct approach to the diagnosis and management of the patient with hypokalemia
IM22.7
OBJECTIVES
1.Definition of Hypokalemia
2.Causes of Hypokalemia
3.Clinical features in Hypokalemia
4.Diagnosis of Hypokalemia
5.Management of Hypokalemia
237
HYPOKALEMIA
LECTURE
Enumerate the causes and describe the clinical and laboratory features and the
correct approach to the diagnosis and management of the patient with
IM22.8
hyperkalemia
OBJECTIVES
1.Definition of Hyperkalemia
2.Causes of Hyperkalemia
3.Clinical features in Hyperkalemia
4.Diagnosis of Hyperkalemia
5.Management of Hyperkalemia
238
HYPERKALEMIA
LECTURE
Enumerate the causes and describe the clinical and laboratory features of
IM22.9
metabolic acidosis
OBJECTIVES
1.Definition of metabolic acidosis
2.Causes of metabolic acidosis
3.Clinical features of metabolic acidosis
4.Lab diagnosis of metabolic acidosis
5.Correction of metabolic acidosis
Enumerate the causes of describe the clinical and laboratory features of metabolic
IM22.10
alkalosis
OBJECTIVES
1.Definition of metabolic alkalosis
2.Causes of metabolic alkalosis
3.Clinical features of metabolic alkalosis
4.Lab diagnosis of metabolic alkalosis
5.Correction of metabolic alkalosis
239
METABOLIC ACIDOSIS AND ALKALOSIS
SGD
PHYSIOLOGY
Enumerate the causes and describe the clinical and laboratory features of
IM22.11
respiratory acidosis
OBJECTIVES
1.Definition of respiratory acidosis
2.Causes of respiratory acidosis
3.Clinical features of respiratory acidosis
4.Lab diagnosis of respiratory acidosis
5.Correction of metabolic alkalosis
Enumerate the causes and describe the clinical and laboratory features of
IM22.12
respiratory alkalosis
OBJECTIVES
1.Definition of respiratory alkalosis
2.Causes of respiratory alkalosis
3.Clinical features of respiratory alkalosis
4.Lab diagnosis of respiratory alkalosis
5.Correction of metabolic alkalosis
240
RESPIRATORY ACIDOSIS AND ALKALOSIS
SGD
PHYSIOLOGY
Identify the underlying acid based disorder based on an ABG report and clinical
IM22.13
situation
OBJECTIVES
1.Arterial blood gas analysis
2.Technique to take arterial blood
3.ABG report analysis
4. Interpretation based on ABG report and clinical status
241
ABG - INTERPRETATION
DOAP
NUTRITIONAL AND VITAMIN DEFICIENCIES
Discuss and describe the methods of nutritional assessment in an adult and
IM23.1
calculation of caloric requirements during illnesses
OBJECTIVES
1. Students should know nutritional value of food materials
2. Nutritional asessment of the food
3. Calculations of the caloric value and requirement of the patient
NUTRITIONAL STATUS AND CALORIC REQUIREMENT ASSESSMENT
242
LECTURE/SGD
Discuss and describe the causes and consequences of protein caloric malnutrition
IM23.2
in the hospital
OBJECTIVES
1. Causes of malnutrition
2. Diffrence between kwashiorkar and marasmus
3. Normal requirement of protein and clinical presentation of protein loss
(hypoproteinemia)
243
PROTEIN ENERGY MALNUTRITION
LECTURE/SGD
PEDIATRICS
Discuss and describe the aetiology, causes, clinical manifestations, complications,
IM23.3
diagnosis and management of common vitamin deficiencies
OBJECTIVES
1. Students should know Fat soluble vitamins
2. Students should know Water soluble vitamins
3. Features of water soluble vitamin defeciencies
4. Features of Fat soluble vitamin defeciencies
5. Daily requirement of vitamin for the body
6. Nutritional or therapeutic supplementation of vitamin in defeciency state
7. Complications of vitamin defeciency
8. Management of vitamin defeciency and its complications
244
WATER SOLUBLE VITAMINS
LECTURE/SGD
BIOCHEMISTRY
245
FAT SOLUBLE VITAMINS
LECTURE/SGD
BIOCHEMISTRY
Enumerate the indications for enteral and parenteral nutrition in critically ill patients
IM23.4
OBJECTIVES
1. Students should know the routes of nutritional supplementation
2. Indications for enteral nutrition
3. Indications for parentral nutrition
NUTRITIONAL STATUS IN CLINICALLY ILL PATIENT AND IT'S MANAGEMENT
246
LECTURE/SGD
Counsel and communicate to patients in a simulated environment with illness on
IM23.5
an appropriate balanced diet
OBJECTIVES
1. Balanced diet - carbohydrates,protein, fat and vitamins
2. Nutritional defeciency assessment of ill patients
3. Supplementation of balanced diet
247
COUNSELLING - NUTRITION AND BALANCED DIET
DOAP
GERIATRICS
Describe and discuss the epidemiology, pathogenesis, clinical evolution,
IM24.1
presentation and course of common diseases in the elderly
OBJECTIVES
1. Describe five epidemiological risk factors for common diseases in elderly-
ALZHEIMER'S DISASE,OSTEOARTHRITIS, FALLS & BALANCE DISORDERS,
URINARY INCONTINENCE
2.Describe the pathogenesis of common diseases in elderly
3.Identify atleast 5 clinical symptoms & 5 clinical signs regarding common disease
in elderly
4.Discuss course of atleast 3 common disease among elderly
248
COMMON DISEASES IN ELDERLY
LECTURE/SGD
Perform multidimensional geriatric assessment that includes medical, psycho-
IM24.2
social and functional components
OBJECTIVES
1.Assess atleast 5 clinically significant anthropometric & physical assessment in
elderly
2.Perform cognitive assessment skills like MMSE in elderly population
Describe and discuss the aetiopathogenesis,clinical presentation, identification,
functional changes, acute care, stabilization, management and rehabilitation of
IM24.3
acute confusional states
OBJECTIVES
1.To list atleast 5 common causes of acute confusional states & describe its pathogenesis
2.To identify atleast 4 clinical presentation & functional changes of acute confusional
states in elderly
3.At the end of lecture should list out the necessary investigations to be done at acute
confusional state
4. Should know the steps to be taken in management of acute confusional state such as
Emergency interventions,stabilisation care
5.Able to describe atleast 5 rehabilitation measures to be done at patient care
249
ACUTE CONFUSIONAL STATE IN GERIATRIC AGE GROUP
LECTURE/SGD
Describe and discuss the aetiopathogenesis,clinical presentation, identification,
functional changes, acute care, stabilization, management and rehabilitation of
IM24.4
vascular events in the elderly
OBJECTIVES
1. Able to list atleast 5 common etiologies & describe its pathogenesis of vascular events
in elderly
2.Should able to list 5 common clinical symptoms & demonstrate common signs of
vascular events in elderly
3. Should be list the necessary investigations & interpret
4.Should demonstarte the important acute interventional skills & stabilisation care
250
VASCULAR EVENTS IN ELDERLY
LECTURE/SGD
Describe and discuss the aetiopathogenesis clinical presentation identification,
functional changes, acute care, stabilization, management and rehabilitation of
IM24 5
depression in the elderly
OBJECTIVES
1. At the end of lecture,student should be able to list atleast 5 etiology & describe
its pathogenesis of deprssion in elderly
2. Able to perform clinical examination of Mental Status Examination & identify &
describe functional status of depression in Elderly
3.
Should know atleast 5 important lab investigations & imaging modalities in
diagnosis of depression in elderly
4. Know the common therapeutic medical interventions in acute care ,stabilisation,
management of depression in elderly
5. Should list out 5 ways of rehabilitation measures in management of depression
in elderly
251
DEPRESSIVE DISORDER IN ELDERLY
LECTURE/SGD
PYSCHIATRY
Describe and discuss the aetiopathogenesis causes, clinical presentation,
difference in discussion presentation identification, functional changes, acute care,
stabilization, management and rehabilitation of dementia in the elderly
IM24.6
OBJECTIVES
1.Should be able to list out atleast 6 neurodegenerative & metabolic causes &
describe its pathogenesis of dementia in elderly
2.Able to discuss various clinical acute, subacute,chronic presentation of dementia
in elderly
3,able to identify & differentiate among varied clinical presentaion of common
neurodegenerative disorders causing dementia in elderly such as
Alzheimer's,Lewy body demtia, Frontotemporal,Parkinsons plus syndrome
4.should know atleast 8 common therapeutic skills in acute care treatment &
stabilisation of depression in elderly
5.Able to enumerate atleast 5 ways of rehabilitaional measures for depression in
elderly
252
DEMENTIA IN ELDER AGE GROUP
LECTURE/SGD
Describe and discuss the aetiopathogenesis,clinical presentation, identification,
functional changes, acute care, stabilization, management and rehabilitation of
IM24.7
personality changes in the elderly
OBJECTIVES
1.should know the common neuroanatomical pathways & its significance , list the
common functions of cerebral cortex responsible for cognitive behaviours &
intellectual functions
2.should be able to list atleast 5 common etiology & describe its pathogenesis for
cognitive behavioural disorders in elderly
3.able to do clinical examination of individual cortical cognitive functions,
behavioural functions & identify specific cognitive dysfunction in elderly 4.should
discuss atleast 5 relevant laboratory investigations & imaging modalities in
daignosis of cognitive dysfunction
5.should list out 5 ways of rehabilitation measures in management of personality
disorder / cognitive dysfunction in elderly
253
PERSONALITY DISORDER IN ELDER AGE GROUP
LECTURE/SGD
Describe and discuss the aetiopathogenesis,clinical presentation, identification,
functional changes, acute care, stabilization, management and rehabilitation of
IM24.8
osteoporosis in the elderly
OBJECTIVES
1.should be able to describe calcium,phosphate mineral metabolism,parathormone
& sigificance of vitamin D metabolism on bone architexture
2. Able to describe roles of numerous hormonal factors, influence of ligands, small
molecules over bone remodelling
3. able to list atleast 5 common clinical symptoms& identify clinical signs of
osteoporosis in elderly
4.able to discuss non pharmacological & pharmacological interventional methods
in acute care ,stabilisation of osteoporosis in elderly
5.able to list out 5 common rehabilitational methods for osteoporosis in elderly
254
OSTEOPOROSIS IN ELDER AGE GROUP
LECTURE/SGD
ORTHOPAEDICS
Describe and discuss the aetiopathogenesis,clinical presentation, identification,
functional changes, acute care, stabilization, management and rehabilitation of
IM24.9
CVA in the elderly
OBJECTIVES
1. able to describe & discuss atleast 5 etiopathogenesis of CVA in elderly 2.should
be able to clinically diagnose common clinical presentations of CVA in elderly
3.able to perform common skillful procedures for acute care,stabilisation for CVA
in elderly
4. should know the most common management strategies for ischemic &
hemorrhagic CVA in elderly
5. should know the most common management strategies for ischemic &
hemorrhagic CVA in elderly
255
CEREBROVASCULAR ACCIDENT IN ELDER AGE GROUP
LECTURE/SGD
Describe and discuss the aetiopathogenesis,clinical presentation, identification,
functional changes, acute care, stabilization, management and rehabilitation of
IM24.10
COPD in the elderly
OBJECTIVES
1. describe & discuss 3 common etiopathogenesis of COPD in elderly
2.should be able to identify clinical signs of COPD in elderly
3.able to discuss pulmonary function test findings as per GOLD classification of
COPD
4.should know common steps of acute xaceberation care & stabilisation -
bronchodilators therapy,steroids,NIV care for COPD in elderly
5. should know pulmonary rehabilitational meaures exercises for COPD in elderly
COPD IN ELDER AGE GROUP
256
LECTURE/SGD
RESPIRATORY MEDICINE
Describe and discuss the aetiopathogenesis,clinical presentation, identification,
functional changes, acute care, stabilization, management and rehabilitation of the
IM24.11
elderly undergoing surgery
OBJECTIVES
1. should describe common surgical procedures as elderly are subjected to undergo -
CAG,OA KNEE - ARTHROPLASTY,WOUND DEBRIDEMENT,AMPUTATION
2. discuss etiopathogenesis of factors affecting surgical interventions in elderly 3.should
be able to assess physical fitness for elderly patients undergoing surgeries
4. Know the common therapeutic medical perioperative interventions in acute care
,stabilisation for elderly patieents undergoing surgery
5.should list 4 rehabilitational strategies for perioperative elderly pts
SURGICAL PROCEDURES IN ELDER AGE GROUP
GENERAL SURGERY AND
257
LECTURE/SGD
ORTHOPAEDICS
Describe and discuss the aetiopathogenesis,clinical presentation, identification,
functional changes, acute care, stabilization, management and rehabilitation of
IM24.12
degenerative joint disease
OBJECTIVES
1. describe & discuss 5 etiopathogenesis of osteoarthiritis in elderly
2.should know imaging modalities such as x ray,CT,MRI in evaluation of osteoarthiritis in
elderly
3. should be able to know common pharmacological & non pharmacological therapeutics
in acute care & stabilisation of osteoarthiritis in elderly
4.should know 5 rehabilitationalk measures for degenerative joint disorders in elderly
258
OSTEOARTHRITIS IN ELDER AGE GROUP
LECTURE/SGD
Describe and discuss the aetiopathogenesis,clinical presentation, identification,
functional changes, acute care, stabilization, management and rehabilitation of
IM24.13
falls in the elderly
OBJECTIVES
1. able to list common neurological , metabolic,polypharmacy causes for falls in elderly
2. able to identify common clinical significant findings leading to falls in elderly orthostatic
Hypotension,bradycardia,peripheral neuropathy,hypoglycemic episodes,cerebellar &
parkinsonian fatures 3.should know common skillful interventions for acute care &
stabilisation for falls in elderly
4.should list atleast 5 rehabilitational & ergonomic measures for falls in elderly
259
ACCIDENTAL FALL IN ELDER AGE GROUP
LECTURE/SGD
Describe and discuss the aetiopathogenesis,clinical presentation, identification,
functional changes, acute care, stabilization, management and rehabilitation of
IM24.14
common fractures in the elderly
OBJECTIVES
1. able to list 5 common predisposed anatomical sites for fractures in elderly
2.able to describe & discuss atleast 5 etiopathogenesis for fractures in elderly
3.discuss the importance of stabilisation,immobilisation ,anesthetic interventions for
fractures in elderly
4. should list out 5 common rehabilitational measures for fractures in elderly
5.atleast 5 rehabilitational care for visual loss in elderly
COMMON FRACTURES IN ELDER AGE GROUP
ORTHOPAEDICS ,
PHYSICAL MEDICINE AND
260
LECTURE/SGD
REHABILITATION
Describe and discuss the aetiopathogenesis,clinical presentation, identification,
functional changes, acute care, stabilization, management and rehabilitation of
IM24.15
vision and visual loss in the elderly
OBJECTIVES
1. should describe visual pathways & its significance
2.describe & discuss etiopathogenesis of common causes of visual impairment in elderly
3.able to identify visual acuity,color vision,common refractive problems,cataract,features
of glaucoma,fundus findings in elderly
4. should know therapeutics in acute car & management of visual loss in elderly
5.atleast 5 rehabilitational care for visual loss in elderly
261
BLINDNESS IN ELDER AGE GROUP
LECTURE/SGD
OPHTHALMOLOGY
Describe and discuss the principles of physical and social rehabilitation, functional
assessment, role of physiotherapy and occupational therapy in the management of
IM24.16
disability in the elderly
OBJECTIVES
1. able to describe 5 basic principles of physiotherapy & occupational therapy for disability
in elderly
2.able to perform anthropometric assessment,functional status of older
individuals,quality of life,degree of dependence for daily living among elderly
3.should be able to enumerate rehabilitational interventions of occupational
care,physiotherapy in managing disability in elderly
ORTHOPAEDICS ,
PHYSICAL MEDICINE AND
262
DISABILITY IN ELDER AGE GROUP
LECTURE/SGD
REHABILITATION
Describe and discuss the aetiopathogenesis,clinical presentation, identification,
functional changes, acute care, stabilization, management and rehabilitation of
IM24.17
hearing loss in the elderly
OBJECTIVES
1. able to describe neuro anatomical pathway of vestibulocochlear nerve & auditory
cortex 3.should demonstrate 5 clinical examination tests related to identification of
auditory function in elderly
2.able to discuss atleast 5 common etiopathogenesis of hearing loss in elderly
3.should demonstrate 5 clinical examination tests related to identification of auditory
function in elderly
4.should know the common steps in acute care , stabilisation & management skills of
hearing loss in elderly
5. able to list 3 rehabilitational measures of hearing loss in elderly
263
HEARING LOSS IN ELDER AGE GROUP
LECTURE/SGD
ENT
Describe the impact of the demographic changes in ageing on the population
IM24.18
OBJECTIVES
1. should list out the current trend of demographagic changes of aged persons in indian
population
2.should list the common 3 social,3 economical, 5 physical & mental health impacts of
ageing in indian population
264
DEMOGRAPHIC CHANGES IN AGEING
LECTURE/SGD
Enumerate and describe the social problems in the elderly including isolation,
IM24.19
abuse, change in family structure and their impact on health.
OBJECTIVES
1. Enumerate atleast 5 social problems among elderly - a) Frailty,
b)Retirement, c)loneliness/isolation,physical & mental abuse
d)family environmental changes in elderly
2.Describe socioeconomical,physical, psychological health impacts owing to above
mentioned social problems in elderly
265
SOCIAL ISSUES IN ELDER AGE GROUP
LECTURE/SGD
Enumerate and describe social interventions in the care of elderly including
domiciliary discussion services, rehabilitation facilities, old age homes and state
IM24.20
interventions
OBJECTIVES
1. should enumerate 7 common care settings for elderly- Hospital acute care,
Inpatient rehabilitationservices,op clinic,post acute care,chronic disease
care,assisted living, home health care,day care programs
2. should know atleast 5 evidence based model in management for social
problems in elderly
266
ELDER AGE - DOMICILIARY AND OLD AGE HOME SERVICES
SGD
IM24.21
Enumerate and describe ethical issues in the care of the elderly
OBJECTIVES
1. should list out 5 common ethical issues in elderly care
2.should be able to describe 3 ethical issues in elderly care
267
ETHICAL ISSUES IN ELDERLY AGE GROUP
SGD
AETCOM
Describe and discuss the aetiopathogenesis, clinical presentation, complications,
assessment and management of nutritional disorders in the elderly
IM24.22
OBJECTIVES
1. should list & discuss 6 etiopathogenesis of common nutritional diorders in elderly
2.able to assess c3.lincial anthroprometric changes,body composition changes due to
ageing in elderly
3.discuss laboratory , imaging & endocrinological investigations to assess nutritional
disorders in elderly
4. should know common RDA - dietatry requirements / supplements of vitamins,minerals,
carb,proteins, lipids for elderly
5.able to describe basic principles & strategies for nutritional therapeutical interventions
in nutritional disorders in elderly
PHYSIOLOGY AND
268
NUTRITIONAL DISORDERS IN ELDER AGE GROUP
LECTURE/SGD
BIOOCHEMISTRY
MISCELLANEOUS INFECTIONS
Describe and discuss the response and the influence of host immune status, risk
factors and comorbidities on zoonotic diseases (e.g. Leptospirosis, Rabies) and
IM25.1
non-febrile infectious disease (e.g. Tetanus)
OBJECTIVES
1. To describe the host immune status on zoonotic and non febrile infectious disease
2. To discuss the list of risk factors and comorbidities on zoonotic and non febrile
infectious disease
Discuss and describe the common causes, pathophysiology and manifestations of
IM25.2
these diseases
OBJECTIVES
1.To describe the mode of transmission and incubation period
2.To describe the morphological characteritics and pathophysiology of leptospirosis
3.To discuss the list of triad of clinical features and ateast 5 common clinical features of
leptospirosis
4.Teatnus - Etiopathogenis and clinical presentation
5.Anthrax- Etiopathogenis and clinical presentation
Describe and discuss the pathophysiology and manifestations of these diseases
IM25.3
OBJECTIVES
1.To describe the mode of transmission and incubation period
2.To describe the structure and pathophysiology of rabies
3. To list the early,additional and late clinical features of rabies
Elicit document and present a medical history that helps delineate the aetiology of
these diseases that includes the evolution and pattern of symptoms, risk factors,
IM25.4
exposure through occupation and travel
OBJECTIVES
1.History to rule out etiology based on symptoms
1.History - Related to travellers infection
2.History - Related to occupation exposure
Perform a systematic examination that establishes the diagnosis and severity of
presentation that includes: general skin, mucosal and lymph node examination,
chest and abdominal examination (including examination of the liver and spleen)
IM25.5
OBJECTIVES
1.General physical examination - lymph nodes, mucous membrane
2. Systemic examination including abdomen - liver, spleen
3. Respiratory system examination - breath sounds and abnormal breath sounds
Generate a differential diagnosis and prioritise based on clinical features that help
distinguish between infective, inflammatory, malignant and rheumatologic causes
IM25.6
OBJECTIVES
1. Difference between infective diseases and inflammatory , malignant and
rheumatological diseases
2. Etiology of infectious diseases
3. Various etiology of rheumatological diseases
4. Causes for malignant diseases
5. Inflammatory signs
269
LEPTOSPIROSIS - ETIPATHOGENESIS AND CLINICAL FEATURES
LECTURE/SGD
MICROBIOLOGY
270
RABIES - ETIOPATHOGENESIS AND CLINICAL FEATURES
LECTURE/SGD
MICROBIOLOGY
271
TETANUS -ETIOPATHOGENESIS AND CLINICAL FEATURES
LECTURE/SGD
MICROBIOLOGY
272
ANTHRAX- ETIOPATHOGENESIS AND CLINICAL FEATURES
LECTURE/SGD
MICROBIOLOGY
Order and interpret diagnostic tests based on the differential diagnosis including:
CBC with differential, blood biochemistry, peripheral smear, urinary analysis with
sediment, Chest X ray, blood and urine cultures, sputum gram stain and cultures,
sputum AFB and cultures, CSF analysis, pleural and body fluid analysis, stool
IM25.7
routine and culture and QBC
OBJECTIVES
1. Interpretation of complete blood count - TC, DC, ESR, Platelet, Hb, rbc, pcv
2. Interpretation of peripheral bloodn smear study - morphology of blood cells and
premature cells
3. Interpretation of biochemical tests - sugar, urea, creatinine, LFT, lipid profile
4. Interpretation of urine analysis
5. Interpretation of chest X-ray, Images
6. Interpretation of blood culture and sensitivity
7. Interpretation of CSF culture and sensitivity
273
INVESTIGATIONS IN ZOONOTIC DISEASES
LECTURE/SGD
MICROBIOLOGY
Enumerate the indications for use of newer techniques in the diagnosis of these
IM25.8
infections
OBJECTIVES
1.Enumerate Common indications for use of newer techniques in diagnosis of zoonotic
disease - Leptospirosis, Rabies,Anthrax
IM25.9
Assist in the collection of blood and other specimen cultures
OBJECTIVES
1. Blood collection for dark field examination of spirochetes
2. Blood culture and peripheral blood smear study
3. CSF analysis
Develop and present an appropriate diagnostic plan based on the clinical
IM25.10
presentation, most likely diagnosis in a prioritised and cost effective manner
OBJECTIVES
1. Investigation plan based on history for leptospirosis
2. Investigation plan based on history for rabies
274
SPECIMEN COLLECTION OF ZOONOTIC DISEASES
DOAP
Develop an appropriate empiric treatment plan based on the patient’s clinical and
IM25.11
immune status pending definitive diagnosis
OBJECTIVES
1. Treatment plan for leptospirosis
2. Treatment plan for rabies
3. Treatment plan for tetanus
4.Treatment of Anthrax
275
MANAGEMENT OF ZOONOTIC DISEASES
LECTURE/SGD
Communicate to the patient and family the diagnosis and treatment of identified
IM25.12
infection
OBJECTIVES
1. Communicate and councelling the patient and the family members about the
diagnosis
2. Communicate and councelling the patient and the family members regarding the
treatment
Counsel the patient and family on prevention of various infections due to
IM25.13
environmental issues
OBJECTIVES
1. Counselling the patient for the prevention of the infectious disease
2. Counselling the patient relatives regarding the prevention of disease
276
COUNsELLING OF ZOONOTIC DISEASES AND ITS PREVENTION
DOAP
TOPIC
THE ROLE OF PHYSICIAN IN COMMUNITY
IM 26.1
Enumerate and describe professional qualities and roles of a physician
OBJECTIVES
1.Professional quality of physician
2.Role of physician in the community
Describe and discuss the commitment to lifelong learning as an important part of
IM 26.2
physician growth
OBJECTIVES
1.Importance of life long learning
IM 26.3
Describe and discuss the role of non maleficence as a guiding principle in patient care
OBJECTIVES
1.Role of physician in harmless practice
2.Non harmfull approach principles of physician
Describe and discuss the role of autonomy and shared responsibility as a guiding principle
IM 26.4
in patient care
OBJECTIVES
1.Role of physician of independent practice
2.Role of physician of shared responsibility practice
IM 26.5
Describe and discuss the role of beneficence of a guiding principle in patient care
OBJECTIVES
1.Physician's moral responsibility in patient care
2.Principles of treating the patient with mercy and charity
IM 26.6
Describe and discuss the role of a physician in health care system
OBJECTIVES
1.Responsibility of physician in health care system
2.Role of physician in health delivery
277
PHYSICIAN- ROLE,PROFESSIONAL QUALITIES AND LIFELONG LEARNING
SGD
278
PHYSICIAN - AUTONOMY AND SHARED RESPONSIBILITY
SGD
279
RESPONSIBILITIES OF PHYSICIANS IN THE HEALTH CARE SYSTEM
SGD
IM 26.7
Describe and discuss the role of justice as a guiding principle in patient care
OBJECTIVES
1.Physician's responsibility of treating the patients equally
2.Physician's responsibility of treating the patients without socioeconomic discrepency
Identify discuss medicolegal, socioeconomic and ethical issues as it pertains to organ
IM 26.8
donation
OBJECTIVES
1.Medicolegal issue in organ donation
2.Ethical issues in organ donation
3.Socioeconomic status in organ donation
Identify, discuss and defend medicolegal, sociocultural, economic and ethical issues as it
IM 26.9
pertains to rights, equity and justice in access to health care
OBJECTIVES
1.Physicians's responsibility in patient's rights,equity and justice
Identify, discuss and defend medicolegal, socio-cultural and ethical issues as it pertains to
IM 26.10
confidentiality in patient care
OBJECTIVES
1.Confidentiality in patient care based on medicolegal and ethical issues
Identify, discuss and defend medicolegal, socio-cultural and ethical issues as it pertains to
IM 26.11
patient autonomy, patient rights and shared responsibility in health care
OBJECTIVES
1.Patient to patient autonomy
2.Patient rights and responsiblity of the physicians based on medicolegal and ethical issues
280
PATIENT RIGHTS AND RESPONSIBILITY OF THE PHYSICIAN
SGD
Identify, discuss and defend medicolegal, socio-cultural and ethical issues as it pertains to
decision making in health care including advanced directives and surrogate decision
IM 26.12
making
OBJECTIVES
1.Physician's decision making in health care delivery
2.Sharing the responsibilty to treat the patient
Identify, discuss and defend medicolegal, socio-cultural and ethical issues as it pertains to
decision making in emergency care including situations where patients do not have the
IM 26.13
capability or capacity to give consent
OBJECTIVES
1.Decision making in the emergency care
2.Decision making in the situtation where the patient is note in the capacity to give
consent
Identify, discuss and defend medicolegal, socio-cultural and ethical issues as it pertains to
IM 26.14
research in human subjects
OBJECTIVES
1.Physician's decision making and ethical issues in human research activities
Identify, discuss and defend, medicolegal,socio-cultural and ethical issues as they pertain
IM 26.15
to consent for surgical procedures
OBJECTIVES
1.Physician's responsibility to get consent for surgical procedures
281
PHYSICIAN'S ROLE IN TREATING EMERGENCY CARE AND CONSENT FOR TREATMENT
SGD
Identify, discuss and defend medicolegal, socio-cultural, professional and ethical issues as
IM 26.16
it pertains to the physician patient relationship (including fiduciary duty)
OBJECTIVES
1.Medicolegal professional ethics between patient and physician
Identify, discuss physician’s role and responsibility to society and the community that she/
IM 26.17
he serves
OBJECTIVES
1.Duty of the physician to serve the society
Identify, discuss and defend medicolegal, socio-cultural, professional and ethical issues in
IM 26.18
physician- industry relationships
OBJECTIVES
1.Physician responsibility of industry relationship
IM 26.19
Demonstrate ability to work in a team of peers and superiors
OBJECTIVES
1.Sharing the responsibility and ability to work with peers and superiors
Demonstrate ability to communicate to patients in a patient, respectful, non threatening,
IM 26.20
non judgemental and empathetic manner
OBJECTIVES
1.Abitilty to communicate to the patients
2.Convey the information about the patient condition in empathetic manner
IM 26.21
Demonstrate respect to patient privacy
OBJECTIVES
1.Physician's role and respect to the patient privacy
282
ROLE OF PHYSICIAN - ETHICAL ISSUES,COMUNICATION AND PRIVACY
SGD
IM 26.22
Demonstrate ability to maintain confidentiality in patient care
OBJECTIVES
1.Maintaining confidentiality in patient care
IM 26.23
Demonstrate a commitment to continued learning
1.Physician's commitement to continued learning
Demonstrate respect in relationship with patients, fellow team members, superiors and
IM 26.24
other health care workers
OBJECTIVES
1.Physician's relationship with team members,superiors and health care workers
IM 26.25
Demonstrate responsibility and work ethics while working in the health care team
OBJECTIVES
1.Physican responsibility while working in health care team follwing ethics
283
PHYSICIAN ROLE-CONTINUED LEARNING,RESPECT WITH HEALTH CARE TEAM
DOAP
Demonstrate ability to maintain required documentation in health care (including correct
IM 26.26
use of medical records)
OBJECTIVES
1.Maintianing medical records
2.Carefull medicolegal documentation
Demonstrate personal grooming that is adequate and appropriate for health care
IM 26.27
responsibilities
OBJECTIVES
1.Physician's personal grooming responsibilities
Demonstrate adequate knowledge and use of information technology that permits
IM 26.28
appropriate patient care and continued learning
OBJECTIVES
1.Uses of information technology in patient care and continued learning
284
PHYSICIAN'S RESPONSIBILITY OF INFORMATION TECHNOLOGY OF PATIENT CARE
SGD
Communicate diagnostic and therapeutic opitons to patient and family in a simulated
IM 26.29
environment
OBJECTIVES
1.Physician's role in communicating the diagnostic option to the patient
2.Physician's role in communicating the therapeutic option to the patient and family
Communicate care opitons to patient and family with a terminal illness in a simulated
IM 26.30
environment
OBJECTIVES
1.Physician's responsibility in explaining the terminal care to the patient family
IM 26.31
Demonstrate awareness of limitations and seeks help and consultations appropriately
OBJECTIVES
1.Awareness of limitation of the illness and consultation of collegues
IM 26.32
Demonstrate appropriate respect to colleagues in the profession
OBJECTIVES
1.Respect to colleagues in the profession
Demonstrate an understanding of the implications and the appropriate procedures and
IM 26.33
response to be followed in the event of medical errors
OBJECTIVES
1.Responsibility of physician in the event of medical errors
285
PHYSICIAN RESPONSIBILITY ,TREATMENT OPTIONS AND EVENT OF MEDICAL ERROR
SGD
Identify conflicts of interest in patient care and professional relationships and describe the
IM 26.34
correct response to these conflicts
OBJECTIVES
1.Declaration odf conflict of interest
2.Correct response of conflict
IM 26.35
Demonstrate empathy in patient encounters
OBJECTIVES
1.Physician's role in patient encounter
IM 26.36
Demonstrate ability to balance personal and professional priorities
OBJECTIVES
1.To balance personal and professional priorities
IM 26.37
Demonstrate ability to manage time appropriately
OBJECTIVES
1.Ability to manage time appropriately
IM 26.38
Demonstrate ability to form and function in appropriate professional networks
OBJECTIVES
1.Physician's responsibility to form and function appropriate function network
IM 26.39
Demonstrate ability to pursue and seek career advancement
OBJECTIVES
1.Ability to pursue and seek career advancement
Demonstrate ability to follow risk management and medical error reduction practices
IM 26.40
where appropriate
OBJECTIVES
1.Physician's role to follow risk management
2.Ability to reduce medical error reduction in practice
IM 26.41
Demonstrate ability to work in a mentoring relationship with junior colleagues
OBJECTIVES
1.To work in a mentoring relationship with junior colleagues
286
PHYSICIAN RESPONSIBILITY,CONFLICT,MEDICAL ERROR REDUCTION TIME MANAGEMENT
SGD
IM 26.42
Demonstrate commitment to learning and scholarship
OBJECTIVES
1.Commitment of learning
2.commitement of scholarship
Identify, discuss and defend medicolegal, sociocultural, economic and ethical issues as
IM 26.43
they pertain to in vitro fertilisation donor insemination and surrogate motherhood
OBJECTIVES
1.Physician's role in invitro fertilization of donor insemination
2.Physician responsibility in surrogate motherhood
Identify, discuss and defend medicolegal, socio-cultural professional and ethical issues
IM 26.44
pertaining to medical negligence
OBJECTIVES
1.Responsibility in medical negligence
Identify, discuss and defend medicolegal, socio-cultural professional and ethical issues
IM 26.45
pertaining to malpractice
OBJECTIVES
1.Responsibility of the physician to malpractice
Identify, discuss and defend medicolegal, socio-cultural professional and ethical issues in
IM 26.46
dealing with impaired physicians
OBJECTIVES
1.Responsibility of the physician dealing with impaired physicians
Identify, discuss and defend medicolegal, socio-cultural and ethical issues as they pertain
IM 26.47
to refusal of care including do not resuscitate and withdrawal of life support
OBJECTIVES
1.Responsibility dealing with refusal of care-do not resuscitate
2.Responsibility of physician dealing with withdrawal of life support
IM 26.48
Demonstrate altruism
OBJECTIVES
1.Physician's responsibility of altruism
Administer informed consent and approriately address patient queries to a patient being
IM 26.49
enrolled in a research protocol in a simulated environment
OBJECTIVES
1.Physician's role in addressing patient queries enrolled in research protocol
287
PHYSICIAN'S ROLE- MEDICOLEGAL NEGLIGENCE,ALTRUISM AND RESEARCH PROTOCOL
DOAP
GENERAL SURGERY